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Abstract 
 
Implementing clinical pharmacy services in Palestinian governmental hospitals is 
seriously needed and recommended.  Many attempts took place  to implement clinical 
pharmacy services within  selected governmental  hospitals in Gaza Strip, but non of 
these attempts was effective in providing wide range of clinical pharmacy services at 
a large scale.  The recent attempt to implement clinical pharmacy services within 
MOH hospitals in Gaza Strip was in the year of 2004 when the General 
Administration of Pharmacy through its Pharmaceutical Quality Improvement 
Committee asked the official permission to start implement such services.  An official 
approval from MOH was gained to start implementing such services.  The objectives 
of this study were first, to describe driving forces and holding back forces that 
affected or may affect the implementation process, second to  set recommendations 
that will help in optimizing the effectiveness of the implementation process.  
A qualitative descriptive study was carried in the General Administration of 
pharmacy of MOH,  the nine governmental hospitals in Gaza Strip in which clinical 
pharmacy services are proposed to be implemented and Al Azhar university.  The 
study sample was key informants from different sectors in the pharmacy field  who 
had  the experience and knowledge regarding challenges that face implementing 
clinical pharmacy services in Palestinian governmental hospitals.  Twenty five Key 
informants were  selected for their knowledge and expertise about the topic. Data was 
collected through using a focus interview loosely structured questions. 
Results showed that implementing clinical pharmacy services in MOH hospitals in 
Gaza Strip still in its primary stage and there are many factors that affect it both 
 8 
positively and negatively.  Factors that would  promote implementing clinical 
pharmacy services  included improving patient's quality of life, economic efficiency, 
provision of an ideal team work and new step towards the profession of pharmacy.  
Factors that would hinder and negatively impact the implementation process included  
administrational and ministerial  changes and instability, inappropriate work place and 
working environment, lack of rewards and motivation, time constrains and work 
overload , lack of mentality regarding the concept of clinical pharmacy and absence  
of knowledge and communication skills and lack of training courses provided to in 
practice clinical pharmacists. Conclusion: implementing clinical pharmacy in 
Palestinian hospitals still in its primary  phase, much to be said and done in order to 
make it an efficient and effective process . 
Recommendation: A number of steps should be considered as pharmacy prepares to 
shift toward a profession-wide, patient- centered practice model. First there must be  a 
law empowerment that support the implementation process. MOH should adopt a 
unifying philosophy of practice that establishes the patient as the primary beneficiary 
of the profession, with the pharmacist accepting shared responsibility with other 
health care professionals  for patient care.  Second, a workshops should be conducted 
for  health care providers to introduce the term ``clinical pharmacy`` to them.  Third, a 
clinical  pharmacy a administration need to be established and it needs to be given an  
authority to organize the clinical pharmacy services and direct it's activities.   
 Fourth, more effective collaboration between pharmacy educators in Al Azhar 
University and decision makers  in the General Administration of Pharmacy of MOH 
will be necessary to improve clinical pharmacists  practices. Pharmacy educators can 
strengthen their effort to develop student's abilities to function as future clinical 
pharmacists professionals. 
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 تحديات تطبيق الصيدلة السريرية في مستشفيات فلسطين الحكومية
 
  
 ملخص الدراسة
 
    .اْ رطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد فٍغطٍٓ اٌذىٍِٛخ ٘بَ ٌٚٛطى ثٗ ثمٛح ٌشذح أٍّ٘زٗ
ٌىٓ ٌُ رٕجخ أي , وبْ ٕ٘بن اٌىضٍش ِٓ اٌّذبٚلاد ٌزطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد لطبع غضح اٌذىٍِٛخ
آخش ٘زٖ اٌّذبٚلاد وبْ فً ػبَ .  ِٓ ٘زٖ اٌّذبٚلاد فً رٛفٍش خذِبد اٌظٍذٌخ اٌغشٌشٌخ ػٍى ٔطبق ٚاعغ
ثطٍت سعًّ ,  ػٕذِب رمذِذ الإداسح اٌؼبِخ ٌٍظٍذٌخ ِٚٓ خلاي ٌجٕخ رطٌٛش  اٌؼًّ اٌظٍذلأً اٌزبثؼخ ٌٙب4002
ٚ ٌمذ  رُ اٌذظٛي ػٍى الإرْ اٌشعًّ , ٌٍجذء فً رطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد لطبع غضح اٌذىٍِٛخ
 ٘ٛ ٚطف اٌؼٛاًِ اٌزً أصشد أٚ ح ٘ذف اٌذساط0ِٓ ٚصاسح اٌظذخ اٌفٍغطٍٍٕخ ثبٌجذء فً اٌزطجٍك فً ٔفظ اٌؼبَ
لذ رؤصش عٛاء ثشىً عٍجً أٚ اٌجبثً فً ػٍٍّخ رطجٍك خذِبد اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد لطبع غضح 
اٌذىٍِٛخ ٚ اٌخشٚط ثزٛطٍبد رغبػذ فً خٍك ثٍئخ ِؤاصسح ٌزطجٍك خذِبد اٌظٍذٌخ اٌغشٌشٌخ فً وبفخ ِغزشفٍبد 
فٍغطٍٓ اٌذىٍِٛخ 
: منهجية الدراسة
صّبٍٔخ ِغزشفٍبد , ٌمذ رُ اعزخذاَ  اٌذساعخ  اٌىٍفٍخ اٌٛطفٍخ فً وً ِٓ الاداسح اٌؼبِخ ٌٍظٍذٌخ فً ٚصاسح اٌظذخ
دٍش رُ ػًّ ِمبثلاد .  دىٍِٛخ رُ اخزٍبس٘ب ٌٍجذء ثزطجٍك اٌظٍذٌخ اٌغشٌشٌخ ثٙب ٚ وٍٍخ اٌظٍذٌخ ثجبِؼخ الأص٘ش
شخظٍخ ِغ ػٍٕخ اٌذساعخ ُٚ٘ خّغخ ٚػششْٚ طٍذلأً ٌؼٍّْٛ فً ِخزٍف اٌّجبلاد فً اٌذمً اٌظٍذلأً ِٓ 
اٌزٌٓ ٌذٌُٙ اٌؼٍُ ٚاٌّؼشفخ ثخظٛص رذذٌبد رطجٍك خذِبد اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد لطبع غضح 
, ٚ لذ جّؼذ  اٌجٍبٔبد ثٛاعطخ ِمبثلاد شخظٍخ رُ فٍٙب طشح أعئٍخ رفزخ ِجبلاد  أوجش ٌٍذٛاس .  اٌذىٍِٛخ
. ٚرغّخ ثبلاعزّبع إٌى رفبطًٍ ِؼٍِٛبرٍخ أوضش ٚضٛدب فٍّب ٌزؼٍك ثّٛضٛع اٌجذش
: نتائج الدراسة
لا صاي رطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد لطبع غضح اٌذىٍِٛخ فً ِشادٍٗ الأٌٚى ٚ٘ٛ ٌٛاجٗ اٌىضٍش ِٓ 
٘زٖ اٌزذذٌبد ٌؼزجش ثؼضٙب ِذفضا ٌزطجٍك اٌظٍذٌخ اٌغشٌشٌخ ٚاٌجؼض اَخش ٌؼزجش ِٓ اٌؼٛاًِ . اٌزذذٌبد
اٌّضجطخ ِٓ ضّٓ اٌؼٛاًِ اٌزً رغبػذ فً الاعزّشاسٌخ فً ِذبٌٚخ رطجٍك اٌظٍذٌخ اٌغشٌشٌخ ٘ٛ اٌزأصٍش اٌجٍذ 
اٌزي ٌزشوٗ رطجٍك اٌخذِبد الاوٍٍٍٕىخ فً رذغٍٓ دٍبح اٌّشضى ٚ اٌفبئذح الالزظبدٌخ ٌٍٕظبَ اٌظذً  ِٓ خلاي 
.  رششٍذ اعزٙلان الأدٌٚخ ِٕٚغ دذٚس الأخطبء اٌذٚائٍخ ٚ  اٌغّبح ثزطجٍك ِجبي جذٌذ ٌٍؼًّ اٌظٍذلأً اٌّخزض
اٌزغٍٍشاد : أِب اٌؼٛاًِ اٌزً أصشد عٍجب أٚ لذ رؤصش عٍجب فً ػٍٍّخ رطجٍك خذِبد اٌظٍذٌخ اٌغشٌشٌخ فزضّٕذ
الإداسٌخ ٚاٌٛصاسٌخ  ٚ لٍخ اٌّؼشفخ ٚاٌزمجً ٌّفَٙٛ اٌظٍذٌخ اٌغشٌشٌخ ثٍٓ اٌؼبٍٍِٓ فً اٌّجبي اٌظذً ثبلإضبفخ 
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إٌى  غٍبة ثٍئخ ػًّ ِٕبعجخ رذفض اٌظٍبدٌخ ػٍى رمذٌُ اٌخذِبد اٌّطٍٛثخ ُِٕٙ فً اٌٛلذ اٌزي ٌُ ٌزُ فٍٗ رذسٌجُٙ 
. ثشىً وبفً أٚ إِذادُ٘ ثبٌّشاجغ اٌؼٍٍّخ إٌّبعجخ ٚاٌضشٚسٌخ  لجً ٚضؼُٙ فً الألغبَ
 
:    التوصيات
ٕ٘بن اٌؼذٌذ ِٓ اٌخطٛاد اٌزً ٌجت ارخبر٘ب ِٓ أجً ضّبْ اٌذظٛي ػٍى خذِبد طٍذلأٍخ عشٌشٌخ رغبُ٘ فً 
دذٚس ٔمٍخ ٔٛػٍخ فً ِجبي اٌؼًّ اٌظٍذلأً ٚ فً اٌذظٛي ػٍى خذِبد طذٍخ رجؼً ِظٍذخ اٌّشٌض ً٘ 
أٚلا  أْ رزجٕى  ٚصاسح اٌظذخ  فٍغفخ ِٛدذح رجؼً ِٓ اٌّشٌض ٘ٛ اٌّغزفٍذ الأُ٘ ِٓ رطجٍك اٌظٍذٌخ . الأُ٘
اٌغشٌشٌخ ِغ اٌزأوٍذ ػٍى اٌذٚس اٌذٍٛي اٌزي ٌؤدٌٗ اٌظٍذًٌ اٌغشٌشي ثٛطفٗ ٚادذا ِٓ اٌفشٌك اٌطجً اٌزي ٌمَٛ 
. ثبٌذشص ػٍى ِظٍذخ اٌّشٌض
ػًّ دائشح  خبطخ ,  صبٌضب.  ػًّ ٚسشبد ػًّ ٌٍزؼشٌف ثبٌظٍذٌخ اٌغشٌشٌخ ثٍٓ  اٌؼبٍٍِٓ فً اٌذمً اٌطجً,  صبٍٔب
. ثبٌظٍذٌخ اٌغشٌشٌخ ٚ اػطبء٘ب وبفخ اٌظلادٍبد ٌزٕظٍُ ػًّ اٌظٍذٌخ اٌغشٌشٌخ ٚالاششاف ػٍى ِخزٍف فؼبٌٍبرٙب
اٌزؼبْٚ ِب ثٍٓ اٌمبئٍّٓ ػٍى اٌزؼٍٍُ اٌظٍذلأً فً جبِؼخ الاص٘ش ثغضح ٚ طٕبع اٌمشاس فً  ٚصاسح اٌظذخ  , ساثؼب
اٌمبئٍّٓ ػٍى اٌزؼٍٍُ اٌظٍذلأً ٌغزطٍؼْٛ ِضبػفخ جٙذُ٘ ِٓ أجً .  ٌزذغٍٓ ٔٛػٍخ خذِبد اٌظٍذٌخ اٌغشٌشٌخ
.  رطٌٛش لذساد طلاة اٌظٍذٌخ ثذٍش ٌىْٛٔٛ إٌٛاح اٌّغزمجٍٍخ ٌٍظٍبدٌخ اٌغشٌشٌٍٓ
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Definitions 
 
ACCP 
American College of Clinical Pharmacy. 
 
Adverse drug reactions 
Unwanted reaction to a medicine, such as a rash or headache, it differs from 
medication error which results from a patient receiving incorrect medication (Bair, 
and Cheminant, 1980). 
 
A philosophy of practice 
A philosophy of practice is a set of values that guides behaviors associated with 
certain acts, it defines the rules, roles, relationships, and responsibility of the 
practitioner. 
 
Challenge 
To ask for facts, a call to prove something, a demanding task or situation, dispute the 
truth or validity (Oxford Advanced Learner's Dictionary of current English, London, 
2004). 
Challenges of  implementing clinical pharmacy services 
Driving forces(support and opportunities) and holding back forces(weakness and 
threats ) that may affect the implementation process. 
Clinical audit 
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Review and assessment of performance of an individual, team, ward, unit or trust in 
the care and treatment of a specialized group of patients (ACCP, 1995). 
Clinical governance 
A framework for continuous improvement in quality of clinical services and the 
maintenance of high standards of care (Haslett, Kay, and Weissfellner, 1990). 
  
Clinical pharmacist 
Clinical pharmacist is  primarily responsible for performing clinical pharmacy 
functions such as patient education and counseling, participation in treatment 
planning and review, drug use reviews, and consultation to medical staff regarding 
drug therapy selection, pharmacokinetics, nutritional support and determination of 
therapeutic endpoints.  
 
Clinical pharmacology 
It is the science  concerned with how systems of therapeutics interact with patients. 
 
Clinical pharmacy 
It is often defined as ``The responsible provision of drug therapy for the purposes of 
achieving definite outcomes that improve a patient's quality of life (ACCP, 2000). 
 
Clinical Pharmacy Administration 
 It is an applied field of study that deals with the research, evaluation and management 
of the patient, the drug, and the clinical practitioner as they relate to patient care 
(Einarson,1988). 
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Clinical pharmacy and pharmaceutical care: 
The two concepts of clinical pharmacy and pharmaceutical care are closely related.  
Of the two, clinical pharmacy has been around the longest and the term is widely used 
(Franklin, 2005). 
 
Driving  Forces 
Supporting and  encouraging  factors that would improve the chances of 
implementing the changes intended to be done. 
 
Drug utilization review 
 The process of reviewing the way in which specified drugs are used in an institution 
against agreed criteria (Stroup, and Dinel, 1985). 
 
ECCP 
European College of Clinical Pharmacy 
 
Holding Back Forces 
 Factors that may suppress, hinder and oppose the change intended to be done. 
 
Hospital pharmacist 
A hospital pharmacist is the pharmacist who works in a hospital, three activities are 
considered the foundation of him, adequate drug selection, drug information and drug 
delivery ( Dipiro, 2005). 
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In Practice Clinical  Pharmacist 
 A term was given to the pharmacists who are chosen to act as clinical pharmacists in 
different hospitals in Gaza  Strip. 
 
Key informants 
Certain individuals who are knowledgeable of the community and target population. 
 
Lack of mentality regarding clinical pharmacy 
Lack of consensus and correct perception and understanding regarding the concept of 
clinical pharmacy. 
 
Medication error 
 Episodes in which a patient receives incorrect medication (wrong dose, wrong drug 
and wrong route) it differs from an adverse reaction where the patient is receiving the 
correct medication but has unexpected response (Summers, et al. 1987). 
 
Medication error reporting scheme 
Schemes that collate and analyze reports of medication errors in order to identify and  
remedy weakness in systems and products (ESCP, 2004).   
 
Medication history 
A complete record of prescribed and over-the-counter medicines taken by an 
individual. 
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Medication information service 
A pharmacy support service dedicated to the provision of information about 
medicines.  Such services are usually staffed by specially trained pharmacists and 
equipped with reference books, key journals and electronic data-searching facilities. 
 
Medicines self-administration schemes 
Schemes in which patients are permitted to take their own medicines while in hospital 
(Leblanc, et al. 2005). 
 
MOH 
Ministry of health. 
 
Parenteral administration 
Administration of medicines by intravenous, intramuscular and intrathecal  injections. 
 
Patient centered practice model 
It is a health model that puts improving  patient quality of life on its top priorities and 
duties. 
 
Patient education/counseling 
The process of giving information to patients about their medicines, in order to help 
them avoid wrong use and to improve the medication use, compliance and outcomes. 
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Pharmacist 
Pharmacists prepare and distribute medications prescribed by doctors and other health 
practitioners. They advise patients on the drugs they take and make sure that they 
avoid dangerous drug interactions (ACCP, 1999). 
 
Pharmacist practice system 
It is a professional practice affecting the public health, safety and welfare. 
 
Pharmacokinetic drug monitoring 
Monitoring of drug treatment by monitoring the levels of the drug in the bloodstream. 
Also known as ``therapeutic drug monitoring`` (ESCP,2004). 
PQIC 
Pharmaceutical Quality Improvement Committee. 
  
Prescribing advice 
Advice concerning the safety, efficacy, convenience or economy of drug treatment, 
given by a pharmacist to a doctor or other prescriber (ESCP, 2004). 
 
Prescription monitoring 
The process of reviewing prescriptions to check for safety and appropriateness 
(ESCP, 2004). 
 
Professional clinical pharmacist 
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He is the clinical pharmacist who attended professional training program for clinical 
pharmacy. 
Protocol development 
The process of collecting information about the safety, effectiveness and cost of 
specific drugs and using it to devise procedures for their use (Siegel, Schneider, and 
Moore, 1984). 
 
Therapeutic drug monitoring 
Monitoring of drug treatment by monitoring the levels of the drug in the bloodstream.  
Also known as `pharmacokinetic drug monitoring` (Leufkens, Heskster, and Hudson, 
1997). 
 
Unit –Dose system 
It is a system of distributing drugs for patients.  Unit refers to the patient, and dose 
refers to the prescribed dose for the patient.  Unit-dose dispensing of medication was 
developed in the 1960s to support nurses in medication administration and reduce the 
waste of increasingly expensive medicines (Murray, and Shojania, 2000). 
 
Ward pharmacy 
The definition of ward pharmacy is that there is a pharmacist (BSc.) working in the 
ward, taking care of everything that concerns medication (Dean, 2000). 
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Chapter 1 
Introduction 
Clinical pharmacy is a commonly used term in pharmacy practice, it is a health 
specialty which describes the activities and services of the clinical pharmacist who 
develop and promote the rational and appropriate use of medical products, it is often 
defined as ``The responsible provision of drug therapy for the purposes of achieving 
definite outcomes that improve a patient's quality of life`` (Helper, and Strand, 1999).  
A clinical pharmacist cooperates with the health team members to ensure 
effectiveness and safety of the patient's drug prescription. The pharmacist educates 
and counsels the patient about self administration of medication and self management. 
Another duty of the pharmacist is to solve any drug related problems of the medicine, 
dosage, administration, adverse drug reaction, toxicity, contraindications and drug 
interactions. Besides that, the clinical pharmacist provide drug monitoring services to 
optimize patient's treatment (Al-Shagha and Zairi, 2001).  
The critical importance of clinical pharmacy arises from the overall goal of clinical 
pharmacy activities which is to promote the correct and appropriate medicinal 
products and services. These activities aim at maximizing the clinical effect of 
medicine, minimizing the risk of treatment induced adverse events and  minimizing 
the expenditures of pharmacological treatments born by the system and by the patient. 
Clinical pharmacy education and implementation in both governmental and non 
governmental sectors is very advanced and widely implemented in many developed 
countries like USA, but for some European countries like Norway more effort must be 
done to update the approach (ESCP, 2004). 
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Because of the critical importance of implementing clinical pharmacy services to the 
patient's quality of life, drug cost, and profession of pharmacy General Administration 
of  Pharmacy and through its Pharmaceutical Quality Improvement Committee 
proposed a project of implementing clinical pharmacy services in Gaza Strip 
Governmental Hospitals, the proposal  gained Ministry of Health ( MOH) official 
approval in the year of 2004.  
Pharmaceutical Quality Improvement Committee (PQIC) was assigned the task of  
selecting hospital pharmacists that will become clinical pharmacists, and the hospitals 
in which the clinical pharmacy services will be implemented. 
Twenty pharmacists were selected based on a personal interview, they were assigned 
into nine governmental hospital in Gaza Strip. 
   The aim of this study is to describe  the challenges of  implementing clinical 
pharmacy services in the Palestinian Governmental Hospitals,  mainly  Gaza Strip 
hospitals , in  order to get to a better understanding that enables us to  act in the light 
of the facts found. 
 
1.1 Objectives 
 
1.1.1     General objective: 
 
To describe the challenges of implementing clinical pharmacy services in the 
Palestinian Governmental Hospitals (mainly Gaza Strip hospitals). 
 
1.1.2    Specific objectives: 
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 To describe  driving forces and holding back forces that may 
affect the implementation of clinical pharmacy services in 
Palestinian governmental hospitals (mainly Gaza Strip hospitals) 
from pharmacist's  key informants point of view.  
 To provide a set of recommendations that would help in full  
implementation of clinical pharmacy services in the future . 
 
1.2 Justification and significance of the study 
 
Clinical pharmacy as a health specialty describes the activities and services of the 
clinical activities and services of the clinical pharmacist to develop and promote the 
rational and appropriate use of medicinal products and medicinal devices, it includes 
all the services performed by pharmacists practicing in hospitals, community 
pharmacies, nursing homes, home-based care services, clinic and other settings where 
medicines are prescribed and use. Clinical pharmacy aims to maximize  safety, quality 
and efficiency of  health system (Clark, 2001). 
 In April 2004, the  Pharmaceutical Quality Improvement Committee  of  Pharmacy 
department of Palestinian MOH proposed a project of implementing clinical 
pharmacy services in Palestinian Governmental Hospitals in order to improve quality 
of health services delivered by the hospitals and to optimize safe, effective and 
economic use of medicines. The purpose of this  study is to describe  the factors that 
hinder and/or encourage the implementation of clinical pharmacy services at the 
Palestinian Governmental Hospitals, mainly Gaza Strip hospitals  which in turn would 
help in developing a data base  that can help in overcoming the obstacles and getting 
the best of the available opportunities. 
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1.3 Geographical  Distribution 
 
Palestinian national authority territories comprise of  two areas separated 
geographically: West Bank and Gaza Strip.  West Bank lies within an area of 5,800 
km west of the Jordanian liver. It has been under Israeli Military occupation, together 
with East Jerusalem since June 1967.  West Bank is divided into four geographical 
regions. Gaza Strip is a narrow piece of land lying on the coast of the Mediterranean 
Sea.  It is very crowded place with an area of 360 km. 
The population in Palestine was  estimated  at 3.7 million at the end of 2003,  out of 
them 2.3 millions (63.3%) in West Bank and 1.4 millions (36.7%) in Gaza Strip. 
According to the distribution of the population by Governorate, AL Khaleil 
Governorate has the highest rate of population at 13.9% of the total population, 
followed by Gaza Governorate 13.0%; AL Quads Governorate comes third with 
10.8%; Jericho Governorate has the lowest rate of population at the end of 2003 at 
1.1% (PCBS, 2004). 
 
1.4 Hospitals in Palestine 
   
In Palestine there are 78 hospitals.  The population to hospital ratio is 47,922.  The 
average bed capacity per hospital is 59.99 beds.  In Gaza Strip (GS), there are 24 
making (30.77%). The population to hospital ratio is 57.098. The average bed 
capacity per hospital is 79.88 beds.  In West Bank including Jerusalem, there are 54 
hospitals making (69.23%). The ratio of population per hospital is 43,844. the average 
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bed capacity per hospital is 51.15 bed.  MOH  owns and operates 23 hospitals with 
2,614 beds (55.9%) for the total beds. There are 11 hospitals with 1,152 beds ( 44.1%) 
of total MOH beds in West Bank and the rest in Gaza Strip. The rest of  Palestinian 
hospitals are NGO`S hospitals, private sector hospitals, police and General Security 
hospitals (PCBS, 2004). 
 
1.5 Health finance 
 
According to Ministry of Finance (MOH) estimation, the third year of Al Aqsa 
Intifada has witnessed a further steep decline in all Palestinian Economic indicators. 
 
1.5.1 National Health Expenditures: 
 
In a study by the World Bank in 1997, it was  estimated the per capita health 
expenditures in West Bank and Gaza Strip at 122 US$ in 1996, which means 8.6%of 
the GDP.  
In 2003, about 18% of all MOH-health care expenditures in Palestine were on 
medications and medical disposals.  About 55% of the MOH budget and nearly half 
of all expenditures in UNRWA and non-governmental sector consist of wages and 
salaries and other forms of employee remuneration. About 13% and 14% of total 
MOH health expenditure were on treatment abroad and other operating cost 
respectively.  
Due to current political crises a deficit in medications and medical supplies by 9.4% 
of total health expenditure was reported to deterioration in Palestinian economy.  
 36 
The percentage of revenue collected from health insurance decreased from 16%in 
1995, to 5.1% in 2000 and  4% in 2001 to 2.4% in 2002  and 2% in 2003 (PCBS, 
2004). 
1.5.2   MOH expenditures on medications, medical disposables and 
            lab reagents: 
 
In 2003, MOH expenditures on medications, medical disposals and laboratory 
reagents was accounted for 17,572,988 US$, which is 17.9% of the total MOH 
expenditure. In addition to the cost of vaccines which was accounted for 1,400,954 
US$. In 2003, despite of the international funds and participation of Ministry of 
Finance(MOF), the deficit in medications medical disposals, and lab reagents was 
account at 9.4% of the postulated expenditure (PCBS, 2004). 
 
1.5.3 Pharmacy and Pharmaceuticals: 
 
Having essential drugs of a good quality and at a low cost is  very important 
especially with current economical status in the Palestinian Territories.  Since 2001, 
drugs and medical supplies finance has decreased due to drop in MOH budget and the 
impact of current situation on MOH total expenditure and finance.  It accounted for 
about 23% of the MOH budget in 2003,  while it has accounted  for about 30% of the 
MOH budget in 1997. 
Despite the international funds , the deficit in medications and medical disposals was 
accounted for 9.4% of the postulated expenditure.  Medication shortage were reported 
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mainly in chronic medications, especially in Insulin, cancer medications and some 
types of pediatric medications (PCBS ,2004). 
 
 
1.6   Uniqueness of Hospital Pharmacy 
 
Hospital pharmacists practice within the framework of an organized structure called a 
hospital.  Traditionally a hospital has been defined in terms of its form and the 
quantitative  nature of its services, hospitals may be classified in different ways by: 
Type of service, ownership, length of stay, bed capacity. The development of hospital 
pharmacy in different countries was vitally affected by educational standards and the 
talent of its practitioner. For pharmacists to function effectively it is essential that they 
understand thoroughly what hospital is, how it is organized, what's its functions are, 
and how the pharmacy services fit into the overall patient care program (Becker, 
Bjornson, and Kuhle, 2004).  
In reviewing the activities of hospital pharmacy practice one must conclude that no 
two hospital practices are alike. Of the major factors that make the uniqueness of 
hospital pharmacy is the organized structure of the hospital, the formalized pattern of 
authority, responsibility and coordination that affects every department of the overall 
healthcare team ( Boardman and Fitzpatrick, 2001). 
There is a physician-pharmacist-nurse-patient relationship in the hospital. The nurse 
interjects his or her professional role in the patient between the traditional physician 
patient roles.  Thus  the hospital pharmacist must work not only with the physician but 
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 also very closely with the nurse. Since the hospital is an institution of and for the 
community, it is influenced heavily by the needs, expectations, and demands of the 
members of the community (Becker, Bjornson, and Kuhle, 2004). 
 
 
 
1.7   Clinical Pharmacy Services 
 
1.7.1 In West Bank: 
 
Till now there is no clinical pharmacy services provided in the governmental hospitals 
in West Bank. 
 General Administration of pharmacy through its Pharmaceutical Quality 
improvement committee is planning for the implementation of clinical pharmacy 
services in the future. 
 
1.7.2 In Gaza Strip: 
 
Since the year of 1998,  several attempts was  made in order to implement clinical 
pharmacy in different Gaza Strip hospitals especially Al-Shifa and Khanyunois 
hospitals. Several individual attempts were made in order to practice clinical 
pharmacy services in different hospital settings, these attempts were made with the 
support of the  Palestinian  General Administration of Pharmacy. In April 2004 the  
Pharmaceutical Quality Improvement Committee  of Pharmacy department of 
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Palestinian MOH proposed  implementing clinical  pharmacy services in Palestinian 
Governmental Hospitals in order to increase quality of health services delivered by 
the hospitals and to optimize safe, effective and economic use of medicines.  
The project gained the support and approval of Palestinian Minister of Health 
 )Annex 2 ). 
In the year of 2004, a list of twenty pharmacist were proposed to  the pilot 
implementing of clinical pharmacy services in nine hospitals in Gaza Strip, (Annex 4 
and 5).  
Selection of these pharmacists was based on their well and desire to act as clinical 
pharmacists, no specific exams took place and only verbal interview was made by  a 
special  committee  of General Administration of pharmacy. 
1.8  Selected hospital pharmacists  to work as clinical pharmacists 
 
The twenty pharmacists whom  were selected by the General Administration of 
pharmacy  were a Bachelor degree holders, non of them had special training courses .  
Prior to the selection  process there was an announcement  that is distributed to all 
hospitals in Gaza Strip, the announcement was about pharmacists who are welling to 
work as clinical pharmacists, the pharmacists who liked and desired to work as 
clinical pharmacists were interviewed, then 20 candidate were selected according to 
their well and desire to act as clinical pharmacist.  The twenty pharmacists were 
assigned to the hospitals, where they originally worked.  So, none of them had to 
switch the pharmacy that they worked in before they had shown an interest to become 
a clinical pharmacist  (Annex 5).  
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 A detailed job and duties guideline was given to  the 20 pharmacists ( Annex 6), this 
guideline organizes the relationship between the pharmacists and other health team 
providers , and describes the duties of the clinical pharmacist.  
Special clinical pharmacy forms  were given to the pharmacists to fill and follow with 
each patient they see in their rotation (Annex 7).  
 Job Description was proposed by the committee and distributed to the pharmacists 
(Annex 8). 
Special orientation session on the  concept of clinical pharmacy was held by the 
pharmaceutical quality improvement committee and the twenty pharmacists attended 
the orientation.  After the orientation, they were named in practice clinical pharmacist 
with the aim of differentiating them from professional clinical pharmacists due to 
their lack of knowledge and expertise regarding clinical pharmacy practice and 
science.  
On July 5, 2005 the pharmacists were asked to start practicing clinical pharmacy 
activities in selected departments of the hospitals they  work in, the selection of the 
specific departments was based on the well and knowledge of the pharmacists and on 
the relationships they had with the departments  health team members ( Annex 4). 
 
1.9  Pharmaceutical Quality Improvement Committee 
 
Pharmaceutical Quality Improvement Committee (PQIC) is a five pharmacist 
committee.  It was named  in March 2004, in order to improve the quality of 
pharmaceutical care provided by pharmacist in different sectors. The committee is 
responsible for implementing clinical pharmacy services in the hospitals, train 
pharmacists to be professional clinical pharmacist, make workshops and training 
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programs with the assistance of pharmacy colleges instructors and other pharmacy 
professionals. 
1.10  Governmental Hospitals that are selected for implementing 
         clinical pharmacy services  
Nine governmental hospitals in Gaza were selected by Pharmaceutical Quality 
improvement Committee  to implement clinical pharmacy in them as 
follows: 
1- Al- Shifa hospital in Gaza city (  Four   pharmacists  were selected  to act as 
clinical pharmacists). 
2- Gaza European hospital  in Khanyunis city (  Four   pharmacists  were selected  
to act as clinical pharmacists). 
3- Khanyunis hospital in Khanyunis city (  Four   pharmacists  were selected  to 
act as clinical pharmacists). 
4- Abu Usif Alnajar  hospital in Rafah  city (One clinical pharmacist).  
5- Kamal Edwan  hospital  in Beet Lahea city (One clinical pharmacist). 
6- Mohammad El Dorah hospital in Al Tefah area in Gaza city (One clinical 
Pharmacist). 
7- Shuhada El Aqsa  hospital in Deer Al Balah  city (One clinical pharmacist). 
8- Al Nasser hospital in Gaza city( three clinical pharmacists). 
9- Al Oyoon hospital in Gaza city(One clinical pharmacist). 
 
1.11 Limitation of the study 
 
The limitation were: 
Limited educational resources like books and journals. 
 42 
Limitation of transportation and mobility between Gaza Strip and West Bank, due to 
the difficult political situation that led to excluding the West Bank hospitals. 
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Chapter 2 
 
Literature review 
 
2.1 Definition of Clinical Pharmacy 
 
Clinical pharmacy is a commonly used term in pharmacy practice and in pharmacy 
literature.  Clinical pharmacy is a health specialty, which describes the activities and 
services of the clinical pharmacist to develop and promote  rational and appropriate 
use of medical products and devices by the individual and the society (Scroccaro, et 
al. 2000). Clinical pharmacy is often defined as the responsible provision of drug 
therapy for the purposes of achieving definite outcomes that improve a patient's 
quality of life (Helper, and Strand, 1999). A clinical pharmacist cooperates with the 
doctors to ensure effectiveness and safety of the patient's prescription (ESCP, 2004).  
The overall goal of Clinical Pharmacy is to promote the rational and appropriate use 
of medicinal products and services, this is achieved through; maximizing the clinical 
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effect of medicines, minimizing the risk of treatment induces adverse events and 
minimizing the expenditures for expenditures born by the National Health System and 
by the patient. The term ``clinical`` does not necessarily imply an activity 
implemented in a hospital setting. A community pharmacist may perform clinical 
activities as well as a hospital practitioner (Scroccaro, et al. 2000). 
There are many definitions of clinical pharmacy, which is understood differently 
throughout the world (ACCP, 2004).  The United Kingdom Clinical Pharmacy 
Association (UKCPA) describes clinical pharmacy encompassing the knowledge, 
skills and attitudes required by pharmacists to contribute to care, the European 
Society of Clinical Pharmacy  defines it as a health specialty that describes the 
activities and services of the clinical pharmacist in developing and promoting the 
rational and appropriate use of medicinal products and devices ( ESCP, 2004). 
 In the Clinical Pharmacy Survival Guide, clinical pharmacy, described as a name for 
a series of patient-services, including prescription monitoring, therapeutic drug 
monitoring and patient counseling. Elsewhere, clinical pharmacy is defined as the 
addressing the pharmacodynamics and pharmacokinetics of drugs in relation to their 
effects on human body. Whatever definition is adopted, it is clear that clinical 
pharmacy is not synonymous with hospital pharmacy. There are two reasons for this. 
First, hospital pharmacy encompasses a much wider range activities, such as 
manufacturing, quality control, supply, procurement, and systems management. 
Second, clinical pharmacy can also be practiced in  community pharmacists ( 
Fitzpatrick  et al ,2005). 
 
2.2  Evolution of Clinical Pharmacy Services 
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The concept of clinical pharmacy spray from a combination of factors, including the 
development of sub discipline of hospital pharmacy since the growth of clinical 
pharmacology, to some extent, pharmacy took over an aspect of medical care that had 
been partially abandon by physician.  Physician turned to pharmacists more and more 
for drug information, especially within institutional settings.  The expansion of 
pharmacy's role to include patient instruction on proper drug use seems a logical 
extension of the pharmacist's role as a tool maker ( Higby, 2004). 
Throughout this century, pharmacy services has experiences a gradual shift away 
from a traditional passive role, emphasizing drug dispensing, toward a more active 
role in disease and patient-oriented approach to pharmaceutical decision. 
The evolution in the responsibilities of pharmacists throughout this century could be 
summarized as follows: 
In the 1940s and 50s the main role of the pharmacist was to compound drugs, then 
pharmaceutical manufactures began to take over this role. In the 1960s hospital 
pharmacists implemented unit-dose drug distribution systems to reduce medication 
dispensing and administration errors. In the 70s and 80s more emphasis was made on 
provision of clinical pharmacy services which are patient focused, drug focused. 
Interdisciplinary, and data driven (Owdaa, 2004). 
Globally speaking the concept of clinical pharmacy sprang from a combination of 
factors including the development of the sub discipline of hospital pharmacy since the 
1920s, the growth of clinical pharmacology since the 1940s and innovative teaching 
Programs in pharmacy schools and colleges in the recent century ( Higby, 2004). 
Two or three decades ago, hospital pharmaceutical services were almost entirely 
concerned with the preparation and dispensing of medicines, with little direct patient 
contact. These technical services are still fundamental to the current services and have 
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become increasingly specialized, but they are now complemented by a wide variety  
of patient focused activities, theses are referred to as clinical pharmacy services. 
Clinical pharmacy services can influence expenditure on medicines and also improve 
safety and effectiveness of medicines` usage (Clark,  2001). 
Pharmacy is evolving from a product-oriented to a patient oriented profession.  This 
role modification is extremely healthy for the patient, the pharmacist, and other 
members of the health care team , the thing which will present pharmacists with a 
number of new challenges, now, more than in the past (ACCP, 2004). 
 
2.2.1 Clinical Pharmacy services and core activities: 
 
Clinical pharmacy services include word round participation, medication chart 
review, patient interview for medication history, therapeutic drug monitoring, adverse 
drug reactions monitoring, medication error monitoring program, patient counseling 
and education, staff education, drug use evaluation, participation in developing 
guidelines and protocols and clinical trial services ( Owda, 2004). 
Clinical pharmacy services always involve the following core activities: 
Prescribing monitoring, prescribing advice, optimizing therapeutic use of medicines, 
adverse drug reaction prevention/detection, prevention and detection of medication 
errors, patient education/counseling and interpersonal education about medicines. 
Clinical pharmacy services aim to optimize treatment of patients during their hospital 
stay and ensure that patients and their careers are equipped with adequate medicines 
management mechanisms to ensure their treatment is continued after they  leave 
hospitals  ( Clark, 2001). 
Four clinical pharmacy services were associated with lower hospital drug cost: 
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In-service education, drug information services, drug protocol management and 
admission drug histories ( Bond, Rahel, and Franke, 1999). 
 
 
 
 
2.2.2  Background knowledge of clinical pharmacist: 
 
In order to make appropriate and correct interventions during the prescribing process, 
clinical pharmacists need both a strong clinical background, as well as evaluation 
tools to correctly judge the evidences available for the treatments. Thus, they need to 
know very well the diseases characteristics and their progression; the characteristics 
of medicines, their mechanism of action, their formulations and the way they interact 
with human body.  In addition , they need to be able to evaluate the real value of a 
drug and analyzing randomized controlled trials; they need to assess risk, analyzing 
epidemiological studies and they need to evaluate the economic burden of a treatment 
related to its advantages to the patient (Scroccaro, et al. 2000). 
A key component of this move towards clinical pharmacy as the standard of 
pharmacy practice was the recognition that pharmaceutical education would need to 
be more extensive and intensive. A series of studies and reports starting in the 1940s 
suggested the need for major changes in the education of pharmacists to meet these 
new demands of the profession and to better serve the health care system and society 
as a whole (Farris, et al. 2001).  
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Byrd in the year of 2002, stated that given the analysis of the health care and 
education environment for clinical pharmacy, the profession outlined and approved a 
new mission for pharmaceutical education encompassing the following key elements:  
 preparing students to function as clinical pharmacy  professionals and 
informed citizens in a changing health care system.  
 generating and disseminating new knowledge, through research, about drugs 
and about systems clinical pharmacy.  
 inculcating students with the values necessary to serve society as caring, 
ethical, learning professionals and enlightened citizens.  
 providing students with scientific fundamentals and the attitudes needed to 
adapt their careers to changes in health care over time.  
 encouraging students to take active roles in shaping the policies, practices, and 
future directions of the profession  (Byrd, 2002).  
2.3   Pharmacy College at Al-Azhar University  
 
Pharmacy education has a responsibility of preparing not only for the present but also 
for the future, even innovating for the future and guiding the course of the profession. 
Pharmacy education should seriously consider placing renewed emphasis on the 
integration of general education outcomes (e.g., critical thinking, decision-making, 
valuing and ethics, communication, social interaction and citizenship, self-learning) 
with professional outcomes to prepare truly patient-centered, caring pharmacy 
professionals 
 ( ACCP, 2000). 
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Al-Azhar university is the main university that provide Bachelor degree of pharmacy 
in Gaza Strip. It is considered one of the most important colleges in Gaza Strip. 
Approximately 78 pharmacists graduate from the college yearly (Palestine Al- Azhar 
university guide, 2004). 
 
 
 
 
2.3.1  The traditional pharmacy programs for getting Bachelor degree 
in pharmacy include the following components: 
General education,  Basic physical and biological science, Biomedical science and  
Pharmaceutical science (Owdaa, 2004). 
 general education (including the humanities, social and behavioral sciences, 
oral and written communication, and computer and information technologies)  
 basic physical and biological sciences and mathematics  
 biomedical sciences (anatomy, physiology, biochemistry or molecular biology, 
immunology, and biostatistics)  
 pharmaceutical sciences  
 clinical sciences (epidemiology, pathophysiology, clinical laboratory 
medicine, physical assessment, health promotion, and disease prevention)  
 practice experiences (in ambulatory, inpatient, and managed-care 
environments; in ethical principle applications and legal issues; and in drug 
information management) (Byrd, 2002). The implementation of these far-
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reaching changes in pharmacy education and practice will not  accomplished 
without overcoming some significant challenges and perceived barriers. These 
included the need to find and organize the additional budget and faculty 
personnel resources to implement an entirely new curriculum . The new 
curricula have also required new classroom and laboratory facilities and new 
preceptor roles, as well as new experiential practice training sites. The need to 
restructure some research and graduate training programs and the 
opportunities to develop new clinical pharmacy residency and fellowship 
programs have also posed challenges. The most significant perceived barrier 
has been the anxiety felt among practicing pharmacists who earned the 
traditional BS degree. The  schools need to make plans to provide 
nontraditional paths for practicing professionals to earn clinical pharmacy  
degrees and have strengthened their continuing-education programs (Byrd, 
2002). 
2.3.2   Pharmacy College at Al-Azhar University Role in Affecting 
          Clinical pharmacy Profession: 
 
Pharmacy College at AL-Azhar university  plays a major role in shaping the 
knowledge of pharmacy graduates. In the year of 2005  pharmacy college started a 
Master degree program in pharmaceutical science which is very vital and important 
for the pharmacy profession.  In 2004 renovation of pharmacy curricula took place, 
new courses regarding clinical pharmacy science was added, this empowers and 
improves clinical pharmacy background of the graduated pharmacists. 
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As stated by the Dean of pharmacy college, there will be clinical pharmacy Master 
degree program within one to two years, this will add much to the profession of 
pharmacy, but at the meanwhile undergraduate pharmacists  usually study mainly 
basic pharmaceutical science but no specialized clinical pharmacy science courses are 
available, there is also a relative under emphasis on team-building and inter-
disciplinary health management skills in the typical pharmacy curriculum. This may 
contribute to the main factor regarding the deficient  knowledge of graduated 
pharmacist to act later on as clinical pharmacists. 
There is a residency program in MOH hospitals and primary health centers to be 
attended by each pharmacy student.  This residency program is part of pharmacy 
curricula of pharmacy collogue at Al-Azhar University.  In this residency program in 
hospitals , pharmacy student must attend the medical morning meeting, participate in 
the medical round with the physicians, look at patients files and recommended test, 
attend the scientific lectures held by the physicians in the medical department then 
spend  residency time in the training day in the pharmacy to recognize hospital drugs 
used, how they are stored, ordered, prepared and dispensed.  This training program 
represents what is a typical clinical pharmacist should practice in the beginning of 
implementing clinical pharmacy service (Palestine, AL-Azhar university  guide, 
2004).  
 In the real word, pharmacists graduates will not practice what they have learned 
about pharmaco-dynamics, histology, and other basic pharmaceutical science.  By 
providing such training program, pharmacists will not feel detached from what they 
have learned academically.   
2.4    Principle Activities Of Clinical Pharmacist 
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Clinical pharmacist have a triple function; first in providing advice to doctors, nurses 
and other health care workers on clinical use of medicines, economic drug utilization 
and safety.  Second, in offering direct patient care services through, for example 
medication history-taking, medicines education and advices. Third, by offering 
managers, including clinical managers; informed advice in respect of medicines 
policy and procedure, again designed to ensure safety, effectiveness and economy in 
medicines use ( Clark, 2001). 
The principle activities of clinical pharmacist include; consulting, selection of drugs, 
drug information ,  formulation and preparation, drug use studies and research, 
therapeutic drug monitoring, clinical trials, pharmaco-economic, and dispensing and 
administration. 
1- Consulting;  means that a clinical pharmacist analyses therapies, advices health 
care practitioner on the correctness of drug in providing pharmaceutical care to 
patients both at hospital and at community level. 
2- Selection of drugs;  by defining ``drug formularies`` or ``limited lists of drugs`` in 
collaboration with hospital general practitioners and decision makers. 
3- Drug information;  seeking information and critically evaluating scientific 
literature, organizing information services for both the health care practitioners and 
the patient. 
4- Formulation and preparation, formulation and preparation of medicinal products 
and devices according to accepted standards to meet specific patient's need 
5- Drug use studies and research; drug use studies, outcome research  and collecting 
data on drug therapies. 
6- Therapeutic drug monitoring; this means studying the kinetics of drugs and      
optimizing the dosage. 
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7- Clinical trials;  planning, evaluating and participating in clinical trials. 
8-Pharmacoeconomic; using the results of clinical trials and outcome studies to 
determine cost effective evaluation. 
9-  Dispensing and administration; studying and developing systems for the 
dispensing and administration of medicinal products and devices to guarantee a higher 
security in administration; a reduction in expenditure and a reduction in medication 
errors (ESCP, 2004). 
Clinical pharmacists activities may also involve some or all of the following; 
Medication history taking. Pharmacokinetic drug monitoring, clinical audit and 
protocol development (e.g. for self-administration of medicines). The effectiveness of 
clinical pharmacy services is critically dependent on the timing on  their delivery.  For 
example, advice on effective prescribing or patient education about how to use a 
medicine to get the best effect are both services that should be delivered before the 
event rather than after a poor choice has been made or a medicine has been taken 
incorrectly (Clark, 2001). 
 
2.4.1 Levels at which Clinical Pharmacy activities influence the 
         Correct Use of Medicine: 
 
Clinical pharmacist has the potential to implement and influence drug related policy 
making decisions on which drugs deserve to be marketed, or be included in national 
and local formularies. 
Clinical pharmacy activities may influence the correct use of medicines at three 
different levels; before, during and after the prescription is written. 
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Before the prescription: The clinical pharmacist monitors, detects and prevents 
harmful drug interaction  adverse reactions and medication errors through evaluation 
of prescription profiles, he  also pays special attention to the dosage of drugs that need 
monitoring. 
During the prescription: Clinical pharmacist can influence the attitudes and priorities 
in of prescribes in their correct treatment. 
After the prescription:  after the prescription is written clinical pharmacist plays a key 
role in communicating counseling patients. Pharmacists can improve patient's 
awareness of their treatment, monitor treatment and improve patient's compliance 
with their medications. As a member of a multidisciplinary team, clinical pharmacist 
also provide integrate part of ``hospital to community`` and vise versa, assuming a 
continuity of information on risks and benefits of drug therapy. This influence 
expenditure on medicines, improve the safety and effectiveness of medicines and 
make a significant contribution to the avoidance of medication errors (ESCP, 2004). 
 
2.4.2   Importance of Clinical Pharmacy Services: 
 
Clinical pharmacy services have been shown to; Identify clinically important drug-
related problems, reduce the incidence of clinically important drug- related problems, 
improve patient education and compliance, improve clinical outcomes, improve cost-
effectiveness and  reduce length of hospital stay(Hammerman, et al. 1999).  More 
complex inpatient care resulting from new technology, higher acuity of illness, and 
shorter hospital stays are placing heavier demands on health care practitioners. These 
trends are reflected in the increasing number, types, and cost of prescribed drugs.  The 
selection, administration, and monitoring of these drugs may best be performed by 
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using an interdisciplinary approach which is best implemented by provision of clinical 
pharmacy services (Torok and Brown, 1992). The direct involvement of a pharmacist 
throughout the medication-use process helps ensure continuity of care and may 
minimize the risk, lower the cost, and improve the outcomes associated with drug 
therapy (Schumock, et al. 2000). 
 
 
 
 
2.5  How clinical pharmacists work 
 
The pharmacy profession is currently presented with the challenge of completing the 
incorporation of pharmaceutical care into daily practice . the pharmacist must accept 
responsibility for each patient's drug-related outcomes to effectively provide clinical 
pharmacy services which includes by definition ``finding and responding to the drug 
therapy problems of the patient`` (Becker, Bjornson, and Kuhle, 2004). 
 
2.5.1 Clinical Staff Pharmacist Practice Model: 
 
Clinical Staff Pharmacist Practice Model is a new model of pharmacy practice that 
integrates staff pharmacists into existing clinical practice has the potential to 
minimize the risks, decrease the costs, and improve the outcomes associated with drug 
therapy.  In this model a departmental committee select pharmacists for participation 
in the new practice model.  Selection is based on assessments of candidates 
motivation, knowledge base, interpersonal skills, and oral communication skills once 
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selected each pharmacist receive a minimum of 80 hours of formalized education and 
training (Nesbit, et al. 2001).  
 
2.5.2  Team Building: 
 
The concept of clinical pharmacy emerged in the late 1960`s as society's economic 
base.  Within this model, the pharmacist was to function as a member of the health 
care team able to apply knowledge, skills, and values to ensure optimal spite of this 
change. Pharmacists should work with other health care practitioner to reduce costs, 
optimize patient outcomes and decrease the frequency of preventable adverse drug 
events. The most important thing in clinical pharmacy work is team building and 
morale  boosting when the availability of other  rewards diminishes.  Activities that 
build team  cohesion, communication, and manual respect should be included at staff 
meetings. Managers should attempt to connect with practitioners on a personal level 
and break down traditional barriers that impede progress, when real problems occur, it 
is important that they are communicated openly and not be de-emphasized or 
dismissed as being unimportant (Boardman, Fitzpatrick, 2001). 
 
2.6   Clinical Pharmacy Administration 
 
Pharmacy administration is the style of acquisition, management, and operation of a 
retail pharmacy, it deals with facts and principles that are appropriately covered under 
economics, accounting, drug marketing, pharmacy management and pharmaceutical 
law. Clinical pharmacy is considered to be that part of practice concerned with patient 
oriented care rather than compounding , dispensing, or distributive functions.  Thus 
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clinical pharmacy Administration may be viewed as the part of pharmacy 
administration that focus on the issue relating directly to patient care. It deals with the 
research, evaluation and management of the patient, the drug, and the health care 
practitioner as they all relate to patient care (Einarson, 1988). 
 
 
  
 
2.7  Management  of  Clinical  Pharmacy Services 
 
The pharmacy manager's basic function is to identify the opportunities for clinical 
services, establish  objectives to provide clinical services, and obtain the required 
resources (Guharoy, 1992).  The past and present management capability within 
pharmacy has been and continues to the implementation of clinical services. 
Extensive use of pharmacy technicians, documentation and evaluation of the cost 
benefits of clinical services, effective pharmacy and therapeutics activities, and 
obtaining the necessary resources on an ongoing basis for clinical services are 
examples of essential pharmacy-manager results (Lipman, 1988). 
For the successful implementation and management of clinical services, the pharmacy 
manager must manage the`` people aspects`` of change; obtain the resources of 
pharmacists` time, space, reference materials, and support system; and then design the 
operational systems that will achieve comprehensive drug-use control and appropriate 
patient outcomes from drug therapy.  Management of a clinical program requires: 
 Recognition of the potential for drugs to cause harm.  
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 Commitment of pharmacists ` responsibility for ensuring appropriate clinical 
outcomes. 
 Analysis of the hospital and how clinical services can best be provided there, 
obtaining resources to establish or gain access to a drug information service 
and  developing resources and support for a pharmacokinetics service. 
 Designing efficient distribution systems supported by automated applications.  
 Adequate technicians staff, developing a pharmacist staff that will gain 
physicians` and nurses` support for clinical programs. 
 Developing an organized approach to keeping staff members up to date on 
new drugs and technology and assisting them in sharing  this knowledge with 
physicians and nurses.  
 Demanding and ensuring the quality of the clinical performance of each 
pharmacist. Documenting and evaluating the cost effectiveness of services 
provided, and recruiting and retaining good pharmacists and technicians  
(Smith, 1988). 
 
 2.7.1 Attitude and Behavior towards drugs: 
 
The first step in the management of clinical pharmacy services is pharmacy managers` 
possession  of an attitude that drugs have substantial potential to cause harm to 
patients. A manager of a clinical pharmacy program must believe in and be committed 
to the concept that pharmacists have a responsibility to ensure a appropriate clinical 
outcomes of patient drug therapy (Guerrero, Nickman, and Bair, 1990). The pharmacy 
manager must demonstrate behavior that results in the implementation of clinical 
pharmacy services. A manager of a ``non clinical`` pharmacy department does not 
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have to possess such an attitude and behavior in order to meet the responsibilities of 
the job (Asmler, 2002). 
 
2.7.2   Pharmacist Time for Clinical Practice: 
 
The manager of a clinical pharmacy program must define a comprehensive list of 
clinical activities for pharmacists. the expected benefits of each activity for the 
patient, physician, and nurse must be descried in the same time, close attention should 
be paid to the pharmacist's time for clinical practice.  In developing such a plan, the 
pharmacy manager will be confronted with his or her own professional philosophy 
regarding pharmacists' practice.  Pharmacists who are not committed to a clinical  
program cannot prepare or "sell" any clinical program to any health professional or 
hospital manager. If you do not believe in clinical services, you cannot sell them to 
anyone or manage such a service. After the clinical plan is completed, the next step is 
to define how the services can best be provided. The basic support services of drug 
distribution, the use of technical personnel, the use of computers and mechanization, 
the physical facilities, and centralization versus decentralization of services are 
analyzed to determine how to create and maximize pharmacists' time for clinical 
practice. The "ultimate" challenge is how to study one's own hospital; to define the 
patient-related drug problems, the facilities, and the attitudes of personnel; and to 
decide how best to provide clinical services (Denisco, 1986). 
 
2.7.3   Clinical Drug Information service: 
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Pharmacists in clinical practice often are confronted with problems that require use of 
the medical library and drug references. It is not efficient to have each clinical 
pharmacist use time to review the literature and develop answers to all the drug 
therapy problems identified (Lipman, 1986).  A centrally located drug information 
services, staffed with professional and clerical personal, will extend the pharmacist's 
clinical practice capabilities. In addition to support for direct patient care, the drug 
information service staff can provide reviews of new drugs and technology for 
presentation to the pharmacy and therapeutics committee and medical  staff for drug 
formulary decisions.   
The management challenge is to obtain resources to establish a drug information 
service or at least obtain access to an established service at another facility (Dzierba, 
1990). 
 
2.7.4  Drug Distribution Support System: 
 
Clinical pharmacy services require drug distribution systems that result in the patient 
receiving the appropriate dose at the proper time.  Pharmacist time for clinical 
practice can be maximized by the development of efficient drug distribution support 
systems.  Unit Dose systems have been an important step forward to increase the 
efficiency and safety of the hospital medication system.  Pharmacy managers need to 
design unit dose systems with the greatest efficiency and with maximal use of 
technical personnel (Al-Shaqha, and Zairi, 2001).  
 
2.7.5  Intra professional  Relationships: 
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Pharmacist practice located in the central pharmacy (in the traditional pharmacy role) 
results in minimal day-to-day working relationships with physicians.  The working 
relationships with nursing can best be descried as confusing, strained, and even 
antagonistic, as each discipline does not fully understand the operational needs of the 
other.  Communications are by telephone are intercom ( or even non existent), and 
conflict often predominates.  Pharmacists who practice clinically in the patient care 
areas work on a face-to-face basis with physicians and nurses. Communications are 
direct and person-to-person. Cooperation, understanding, and quality services for the 
patient are the results (Bruce, et al 1996). A management challenge in implementing a 
pharmacist clinical practice is to gain the understanding and support of physicians and 
nurses.  Pharmacy managers must understand that the justification for pharmacist 
clinical services is based on the inadequacies of physicians and nurses to prescribe, 
administer, regulate, and monitor drug therapy safely and effectively (Muzzin, 
Hornosty, and Brown, 1993).  To  develop effective ongoing professional 
relationships between pharmacists and physicians and pharmacists and nurses require 
respect for each other's profession, clinical drug knowledge, communication skills, 
ability to work with people, honesty, credibility, and responsiveness to the needs of 
the other professionals (Al-Shaqha, and Zairi, 2001).   
 
2.7.6  New Drugs and Technology: 
 
A clinical pharmacy program is confronted with the necessity for pharmacists to keep 
up with the latest developments in new drugs and technology.  The need for 
pharmacist to keep up on new drugs and technology and to be recognized and used as 
experts on drugs is a big challenge before each pharmacist.  The management 
 62 
challenges are the development of an organized approach to help staff pharmacists to 
meet this challenge and then to share their knowledge and information with the 
medical and nursing staffs (Smith, 1988).   Physicians and nurses need to know and 
understand new drugs and technology to help insure appropriate clinical outcomes of 
patient drug therapy (Fink, et al. 1982). 
 
 
 
  
2.7.7 Quality Assurance of Clinical Services: 
 
Quality services depend on the drug knowledge and skills of the clinical pharmacist.  
Clinical drug knowledge, ability to communicate knowledge, ability to work well 
with others, and performance results are some essential capabilities of the clinical 
pharmacist.  Pharmacy managers can not assume that every pharmacist can perform 
clinically.  The pharmacy director is responsible for all pharmaceutical services; 
therefore, specific plans must be made to attract qualified pharmacists and then 
evaluate the performance of each clinical pharmacist.  Some clinical programs are 
now requiring pharmacy department certification of competence for selected clinical 
activities (Jeffery, and Gallina, 1980). 
 
2.7.8  Cost-effectiveness of Clinical Services: 
 
From the beginning , clinical pharmacy services have been challenged by hospital 
administration, physicians, and  nurses to prove cost-effectiveness.  The management 
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challenge is for each clinical pharmacy program to document and evaluate the cost-
effectiveness of the services provider   (Smith, 1988).  
 
 2.7.9  Pharmacy Personnel: 
 
The unique management challenge relating to pharmacy personnel is the recruitment 
and retention of pharmacists and technicians who are knowledgeable and who can 
work cooperatively with physicians , nurses, other hospital personnel,  and each other.  
Pharmacy personnel in a clinical program practice in the patient-care areas and are in 
frequent contact with other professionals. Their conduct and performance must gain 
the support and confidence of physicians and nurses (Smith, 1988). If educated and 
trained personnel can not be recruited, then the management challenge is to provide 
the necessary education and training of existing staff for their new clinical practice.  
This education and training effort can be successful if it is planned properly, if time is 
made available for the staff, and if the staff members have the desire , motivation to 
learn and change their practice (Phillips, et al. 1987).  
 
2.8 Challenges  of implementing clinical pharmacy services 
 
Globally speaking many counties are trying to broaden the implementation of clinical 
pharmacy services in its hospitals, many factors influence the implementation process 
both positively and negatively, by reviewing and studying the experience of other 
countries we will be able to learn how to deal with the issue locally (Shane, 1996).  
Challenges for the implementing of clinical pharmacy services will be coping with 
increasing workload and limited resources; maintain training pharmacists` 
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competence ;planning for pharmaceutical services by patient care type and setting, 
continually evaluating need for current and new services, and developing a multilayer 
plan; and coping with rapid change (Einarson, 1988). 
Pharmacists gradually are embracing changing professional roles and responsibilities, 
several factors may serve to impair the adoption of new roles as follow: 
 Lack of consensus regarding the professional goals. 
 Resistance to broadening the pharmacists responsibilities beyond dispensing 
Functions. 
 Lack of professional competence and /or self- confidence. 
 Work environment that provide little or no opportunity to provide  patient-
centered  
       practice.  
 Lack of recompense for pharmacist's clinical services 
 Underdevelopment of practitioners interpersonal skills 
Factors that appear likely to promote changing professional roles include 
opportunities to positively Impact patients` drug therapy outcome through disease 
state management, expanded use of technology and technicians in the dispensing 
process, increased demand for drug information among health professionals and 
consumers (ACCP, 2000). 
An example of how the pharmacist role is expanded can be understood by reviewing 
the following example, the code of ethics of Ameican Pharmaceutical Association 
(APhA) which was stated in 1952 until its revision in 1969, this code says that :  
`` the pharmacist does not discuss the therapeutic effects or composition of a 
prescription with a patient`` 
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When any question to be asked , the pharmacist  should suggest that the qualified 
practitioner (i.e. physician or dentist ) is the proper person with whom such matters 
should be discussed. 
After the revision in the year of 1969, the APhA  revamped its code of ethics in the 
face of the large changes occurring in pharmacy. In stead of  referring to physicians, 
the APhA  advanced this statement on the first section of its code: 
`` A pharmacist should hold the health and safety of patient to be of first 
consideration, he should render each patient the full measure of his ability as an 
essential health practitioner`` this clinical pharmacy practice bridges the gap between 
professional and lay understanding of drug action (Higby, 2004). 
 
2.9 Factors that Prompt Changing Pharmacy Roles 
 
Multiple factors can prompt changes in professional roles: 
1-With increased prescribing comes more frequent medication-related problems a 
major area for pharmacist intervention, through the past 30 years numerous 
publications have detailed significant health care problems associated with drug 
related morbidity and mortality, for each 1$ spent on medications in nursing homes, 
1.33$ is expended for drug related problems.. 
2- a small percentage of patients account for a high percentage of health care costs, 
disease state management for patients with chronic medical conditions that contribute 
to high resource utilization increasingly is being conducted through an 
interdisciplinary collaboration of health care professionals including nurses , primary 
care physicians, specialist physicians and pharmacist. 
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3- increased recognition of the need to impact clinical, economic, and humanistic 
patient outcomes, pharmacists are well positioned to apply the scientific method 
effectively to outcome analysis. 
4- Pharmacists are often the health  care professionals who have the greatest 
knowledge and skills to prevent, detect, monitor, and resolve drug-related problem. 
Pharmacists remain highly trusted and readily accessible to the public (ACCP, 2000). 
 
 
 
2.10  Factors that Hinder Changing Pharmacy Roles 
 
All new concepts face barriers and challenges, and concept of clinical pharmacy is not 
an exception, although the profession of pharmacy has embraced clinical pharmacy as 
its new mission, the implementation of clinical pharmacy services as its new mission 
has been slow (Newton, 2004).  
A variety of factors may  impede pharmacists ability to implement clinical pharmacy 
services. The barriers discussed below are not the only difficulties that will be faced, 
nor are they arranged in any particular order or importance.  
 
2..10.1   Individual pharmacist characteristics (Pharmacist –related 
barriers): 
   
Individual pharmacist attitudes and background knowledge and/or skill deficiencies 
may hamper the implementation of clinical pharmacy provided care in any practice 
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setting. For example some pharmacists have grown quite comfortable with traditional 
practice functions and may be fearful about changing to assume new unfamiliar role. 
The provision of clinical pharmacy services will require pharmacists to update their 
professional knowledge and skill base, first and foremost, pharmacists must develop a 
through understanding of what it means to provide clinical pharmacy services (ACCP, 
2000). Pharmacists who commit to managing the pharmacotherapy of their patients 
must be familiar with current advances in the treatment of common diseases, and with 
literature resource/database that are available to assist them to make sound therapeutic 
decisions. The provision of clinical pharmacy services requires that pharmacists 
develop strong, effective problem-solving skills by benefiting from additional 
instruction on clinical problem solving.  Oral and written communication skills are 
central to the provision of clinical pharmacy services.  Strong communication skills 
are crucial for eliciting important information from patients, documenting pharmacists 
therapeutic  decisions and counseling patients about proper use of medications.  
Strong communication skills are essential to convey information about patients` 
pharmacotherapy to physicians and other health care providers (Higby, 2004).  Most 
pharmacists, lack sufficient time to provide clinical pharmacy services. The 
pharmacist's hospital pre-occupation with dispensing drug products may constitute 
one barrier to the acceptance of this new philosophy among product oriented 
practitioners. Drug distribution contributes to their major responsibility, patient care 
activities are a secondary focus, and are often performed when there is spare time or 
extra staff are available (Vree, 1990). 
Pharmacists may fail to accept and fulfill the  clinical pharmacy concept for the 
following reasons: 
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 Some pharmacists do not understand the responsibility for ensuring 
appropriate outcomes and believe that consultation and education are the only 
ingredients of clinical pharmacy. 
 Pharmacists tend to stick to their traditional role.  They continue to direct their 
energies towards product and service empowerment rather than focusing on 
patient. 
 Many pharmacists are eager to become involved in patient and may be 
misdirected into providing patient care services that do not draw on their drug 
expertise. These functions may duplicate the work of other health-care 
professionals and may not contribute to the goal of ensuring the best drug 
therapy outcomes. 
 Pharmacists are not accustomed to clinical pharmacy , and many lack an 
appreciation of its importance (Al-Shagha and Zairi, 2001). 
  
2.10.2  Practice-Setting Constrains: 
 
Resource constrains and other factors associated with a pharmaceutical practice are 
mentioned frequently as barriers to the provision of clinical pharmacy services. 
For example pharmacists often complain that they do not have time to provide clinical 
pharmacy services in addition to their normal responsibilities. A lack of financial 
resources also is mentioned often as barrier to the provision of clinical pharmacy 
services. A gradual transition to the provision of clinical pharmacy  also may be an 
effective means for pharmacists  contend with barrier in the practice setting (Deniso, 
1986). 
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2..10.3  Intra professional  Barriers (professional and administrative 
          barriers): 
 
There is a lack of demand on the part of patients, clinicians, and administrators for 
pharmacists to take responsibility for ensuring appropriate drug therapy outcomes.    
This can be explained by the lack of well controlled studies on the benefits of clinical 
pharmacy services, and the general failure of the pharmacist profession to promote 
adequately the impact the pharmacists can have on patient care overall costs.  The 
value of clinical pharmacy is simply not being perceived.    Patients are familiar only 
with the traditional role of pharmacists, and have  not been taught the need for follow-
up beyond drug dispensing.  Other health care professionals  are generally  not aware 
that clinical pharmacy  complements their own roles, that  it meets  a unique need , 
and does not duplicate or threaten their roles.  Pharmacists may be responsible for this 
lack of understanding (Watanabe, et al. 2005).  Most pharmacists lack the 
communication skills necessary to promote clinical pharmacy to their collogues.  
Physicians as a group may resist a pharmacist's taking  a more active role in patient 
care.  Nurses too may view the presence of pharmacists on the unit as  a threat (Poole, 
and Timothy, 2005).   Administrations of most health care plans do not know that 
pharmacists can make contributions well beyond their traditional distributive duties.  
They do not hold pharmacy managers as accountable for ensuring appropriate drug 
therapy outcomes (Raiford, Clark, and Anderson, 1991). Professional organizations, 
regulatory bodies, and school/colleges of pharmacy also may perceived as barriers to 
the implementation of clinical pharmacy services insofar as their efforts fail to support 
practitioners adequately in their transition efforts.   Colleges of pharmacy must 
assume a variety of roles to support the transition to clinical pharmacy.  They must 
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continually evaluate and modify their professional curricula to ensure that pharmacy 
graduates are prepared to assume contemporary patient care roles. They must assess 
the continuing education needs of their alumni and provide instructional opportunities 
for practicing pharmacists to develop further the professional knowledge and skills 
required to render clinical pharmacy  (ACCP,2000). 
 
 
 
 
2.10.4   System Impediments ( system related barriers): 
 
 It is likely that some health care professionals will resist pharmacist's assumption of 
patient care role. For example, nurses and physicians may review pharmacist 
management of pharmacy therapy as an encroachment on their professional territory.  
Pharmacists should not be intimidated and/or discouraged by  this lack of acceptance. 
Rather, they should forge relationships with health professionals one at time, 
beginning with those individuals who are open to collaboration. Realistically, not all 
health professionals will completely accept pharmacist's expanded role, over time and 
with perseverance, most pharmacists will be able to establish themselves as integral 
members of the health care team  (Newton, 2004).  
A  major system related barrier in health care settings is lack of a comprehensive, 
ongoing process for defining the appropriate outcomes of drug therapy, for employers 
and other purchasers to understand the quality of the health care , defining the quality 
and appropriateness of outcomes is needed . The health care system has became 
highly fragmented.  There is a clear separation between activities in inpatient acute 
 71 
care and activities in outpatient care. A less fragmented system is needed to allow for 
continuity of provision of clinical pharmacy services (Louie and Robertson, 1993).  
Physical facilities limit the ability of pharmacists to provide pharmaceutical care. 
Dedicated areas, in which the pharmacist can provide patient consultations or drug 
therapy information, are often lacking (Penna, 1990). Lack of ready access to clinical 
information limit the ability of pharmacists to provide care that ensures the 
appropriate drug therapy outcomes.  The information to which the pharmacist 
includes the reason for the patients visit and admission, the patients medical history, 
laboratory test results, and the patient's assessment and care plans made by other 
providers (May, 1993).  Information can be obtained from the patients themselves, 
from observation, and from physicians who are willing to provide it, once they know 
the purpose for which it is used.  Consequently, unnecessary personnel and 
administrative costs are incurred, as pharmacists attempt to carry out their tasks of 
identifying potential or actual drug related problems. Patients may resist the adoption  
of clinical pharmacy  for a variety of reasons. Some may be reluctant to spend 
additional time consulting with a pharmacist.  Others may be concerned about cost, 
some patients may feel that pharmacist is trying to take over a portion of the 
physicians` role and want to avoid angering their own doctor. In this context, 
pharmacist should take the time to explain their service thoroughly to each patient. 
They should emphasize that clinical pharmacy  complements  rather  than duplicates 
services provided by other health professionals. In addition pharmacist should 
describe how patients benefit from clinical pharmacy services  (Louie and 
Robertson,1993). 
A national survey was conducted in the year of 1991 by university of Texas in order 
to know the hospital administrators` perceptions of pharmacy directors.  The hospital 
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administrators believed that pharmacy directors in general need to improve their 
relationship with the nursing staff, their basic managerial skills, and their 
communication skills. They believed that the pharmacy director at their own 
institution excelled at keeping up with progressive pharmacy practice, inventory 
management, and interacting with the pharmacy and therapeutics committee. The 
administrators indicated that it is very important for the pharmacy department to be 
involved in therapeutic drug monitoring and medication counseling and to be 
progressive in their offerings of services. Hospital administrators had a positive 
perception of the abilities of pharmacy directors but believed that there is still room 
for improvement (Raiford, Clark, and Anderson, 1991). 
 
2.10.5  Management or department related barriers: 
 
Pharmacy managers in acute care settings often fail to hold pharmacists and other 
pharmacy managers accountable for drug therapy outcomes.  Job description and  
performance evaluation criteria for pharmacists in hospitals still reflect traditional 
functions and accountabilities (Gouveia, 1993).  Managers and pharmacists do not 
jointly develop standards of competence in the area of clinical pharmacy. Evaluation 
and accountabilities are not related to drug therapy outcomes. Many pharmacy 
departments create a barrier to pharmaceutical care when they design their 
organization chart. Pharmacy managers lack sufficient time to plan for clinical 
pharmacy services and for an evolving, patient centered practice. The daily 
responsibilities of pharmacy managers are overwhelming and leave little time for 
innovation ( Louie and Robertson, 1993).  Current accountability structures motivate 
pharmacy managers to concentrate on drug products rather than the outcomes of drug 
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therapy. Most pharmacy managers do not take the risk necessary to demonstrate cost 
effectiveness of the clinical pharmacy model.  They do not adjust the department's 
cost structure to create even small opportunities to demonstrate the cost effectiveness 
( Helper, 1990).  Pharmacy managers also lack integrated mechanisms for measuring 
the impact of services on patient care, there is little consensus abut what measures 
should be and few resources are devoted to developing them ( Helper, 1993).  In large 
hospitals , the responsibilities for clinical and distributive activities are divided 
between pharmacists who are clinically- oriented and pharmacists who are 
distributive- oriented.  This division is not efficient and wastes time.  Organization 
charts should be redrawn, so that all pharmacists may contribute to clinical pharmacy 
(Gouveia, 1993). 
       
2.11  Implementing of clinical pharmacy services and Provision of 
          Clinical pharmacy services in different hospitals 
 
Clinical pharmacy is practiced in many countries and makes a significant contribution 
to improved drug therapy and patient care. Much benefit could be gained by 
reviewing the experience of other countries regarding implementation of clinical 
pharmacy services in its hospitals. 
 
2.11.1   Israel hospital pharmaceutical services: 
 
A national survey was conducted in 1996 to evaluate the hospital clinical pharmacy 
services in Israel hospitals, survey results showed that the main services provided at 
 74 
hospital pharmacies are production of pharmaceuticals, and inventory management.  
The pharmacy directors estimated that more than half of their pharmacists` time was 
spent on technical work that did not need their academic, professional knowledge.  In 
Israel general hospitals there are on average 1.23 full time pharmacist position per 100 
hospital beds and 1.09 positions for other pharmacy employee. A similar survey 
carried out in the United States showed an average of 7.4 pharmacists per 100 hospital 
beds. Pharmacists there have broad clinical roles which, in general Israeli pharmacists 
do not have. Computer systems are used in Israel pharmacies mainly for inventory 
management. About half of the directors did not think that the location, structure and 
furnishings of their pharmacy were appropriate for its role. Under current conditions, 
Israel hospital pharmacies are not organized to provide pharmaceutical services 
beyond inventory management and pharmaceutical production. Appropriate budgets 
and personnel are required to develop clinical pharmacy services at Israel hospitals. 
(Livny, et al. 2000). 
 
2.11.2  Clinical Pharmacy Services in some of US A hospital: 
 
  In Florida hospitals a survey conducted in 1977 was re administered in 1984 in order 
to ascertain the progress made in the implementation of clinical services in Florida 
hospitals, Services such as patient monitoring, in-service education, and drug-use 
review were being offered substantially more than in 1977. Conducting patient 
medication histories, attending rounds with physicians, and providing discharge 
consultations were the least-performed clinical services. The reasons given for not 
implementing these services were similar in both surveys. However, while the lack of 
adequately trained pharmacists was frequently cited in 1977, very few respondents 
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cited it as an obstacle in 1984. Several respondents indicated that they had 
documented cost savings attributable to their clinical pharmacy services. Clinical 
pharmacy programs are continuing to grow in Florida hospitals; however, pharmacy 
administrators appear to be having some of the same problems implementing these 
services as they did previously (Salem, and Doering,  1984). 
In order to assess the  effect of state legislation expanding the scope of pharmacy 
practice in health-care institutions, California hospitals were surveyed in 1982 and 
1986 about pharmacists' regulation of drug therapy. The two surveys  indicated  that 
between 1982 and 1986 pharmacists became more involved in  regulating drug 
therapy in California hospitals (Guglielmo, Schweigert, and Kishi, 1998).  An 
extensive survey of hospital clinical pharmacy services in the Great Lakes region 
showed that that the provision and scope of many services were related to hospital 
size, hospital teaching affiliation and the education of the pharmacy director (Raehl, 
Bond, and Pitterle, 1990).  A national survey of pharmaceutical services in federal 
hospitals was conducted from My to July 1993.  The results showed that a 
computerized pharmacy system was present in 99% of the departments. More than 
95% of hospitals participated in adverse drug reaction, medication error management, 
and drug-use-evaluation programs. A total of 93% provided drug therapy monitoring, 
and 89% provided patient education. About 70% provided written documentation of 
pharmacist interventions in the medical records, and 57% participated in drug 
research. A total of 42% provided pharmacist-managed drug clinics, 41% participated 
in drug management of medical emergencies, 30% provided written medication 
histories, and 30% provided drug therapy management planning. Pharmacokinetic 
consultations were provided by 64% of departments. About 90% had a well-
controlled formulary system and prescribing restrictions. Therapeutic interchange was 
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practiced by 64%. Diversified pharmaceutical services included telephone or mail-in 
refill services (80%), mail-out pharmaceutical services (58%), and services to long-
term-care facilities (49%). A total of 70% of the hospitals were affiliated with a 
pharmacy school (Crawford, and Santell, 1993). A study was conducted in 2000 to 
evaluate the relationship and association among clinical pharmacy services, 
pharmacist staffing and total cost of care in the United States hospitals, the result of 
this study suggest that increased staffing levels of clinical pharmacist and pharmacy 
administrators, as well as some clinical pharmacy services, were associated with 
reduces cost of care in United States hospitals (Bond, Raehl and Franke, 2000).  
Another study was conducted in 2001 to evaluate the interrelationships among 
mortality rates, drug costs, total cost of care and length of stay in United States 
hospitals and clinical pharmacy services provided, the results of the study showed that 
clinical pharmacy services were associated with improvement in the four variables 
(Bond, Raehl, and Franke, 2001).  There is a direct relationships and associations 
among clinical pharmacy services, pharmacist staffing, and medication errors in 
United States hospitals. As staffing of clinical pharmacists increased, medication error 
decreased  (Bond, Raehl, and Franke, 2002).   
2.11.3 Clinical Pharmacy Services in  United Kingdom 
                Hospitals: 
Provision of Clinical pharmacy services in United Kingdom hospitals varied greatly 
through the past decade, in 1986 clinical pharmacy practice centered around drug 
monitoring (word pharmacy). Pharmacokinetic services were provided in few places, 
Master of science degree in clinical pharmacy was available (Cronin, 1986). 
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A survey of clinical pharmacy services  was conducted in  1994 in order to study the 
extent to which clinical pharmacy services are provided in National Health Service 
(NHS) hospitals in the United Kingdom .  Services commonly provided were 
inpatient drug therapy monitoring (96%), clinical trials support (92%), formulary 
management (89%), participation in drug and therapeutic committees (97%), and an 
on-site drug information center (60%). Services infrequently provided were 
therapeutic drug monitoring (21%), medication history-taking (16%), and a 24-hour 
on-site pharmacist (10%). 
Several services were associated with pharmacies that employed many pharmacists, 
pharmacists with advanced education, or specialist clinical pharmacists and 
pharmacies located in medical school teaching hospitals. U.K. hospital pharmacies 
provided fewer patient-oriented services and more drug information, therapy 
monitoring, and pharmacist education services than U.S. hospital pharmacies. 
Provision of clinical pharmacy services in the United Kingdom was associated with 
employment of many pharmacists, pharmacy clinical specialists, and pharmacists with 
advanced education (Cotter, Barber, and Mckee, 1994). 
 
2.11.4    Clinical Pharmacy Services in Northen Ireland hospitals: 
 
By reviewing clinical pharmacy services in Northern Ireland it was found that clinical 
pharmacy services increasingly seen to be critical to patient care particularly because 
they provide an important element of risk management in an inherently risk-laden 
area.  Clinical pharmacists made  numerous routine interventions concerned with 
improving the safety and efficacy of drug therapy. A small but significant number of 
these are potentially life-saving and many improve the quality of life. 
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Clinical pharmacists have successfully identified opportunities for efficiency savings 
and have put them into effect through judicious use of policies and guidelines. 
The importance of continuity of clinical pharmacy services across the 
primary/secondary care interface has been recognized and some services have been 
developed.  Overall, good quality pharmacy have been developed in Northern Ireland 
( Clark, 2002).  
 
 
2.11.5 Challenge of Implementing of Clinical Pharmacy Services in 
           Malaysia:  
 
In order to report  the current status, and future trends of clinical pharmacy practice in 
Malaysia, data on areas related to clinical pharmacy practice in Malaysian hospitals 
were gleaned from previous publications, the report showed that Malaysia is capable 
of implementing clinical pharmacy services in hospitals and perhaps also in  the 
community setting. The important factors in clinically oriented pharmacy practice 
include improvement of the drug-control process, development of  physical and 
human resources, clinical pharmacy skills, and the training of practicing pharmacists. 
A number of Malaysian pharmacists have already developed a unit-dose drug 
distribution system, patient counseling, therapeutic drug monitoring, drug 
information, and total parenteral nutrition services. The pharmacy profession in 
Malaysia has many challenges ahead and it is hoped that every practicing pharmacist 
will be highly committed to future professional needs so that clinical pharmacy 
practice in Malaysia becomes a reality (Hassan, 1993). 
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2.11.6  Implementing Clinical Pharmacy Services in  South Indian 
           Teaching hospital: 
 
Medication use problems are commonly encountered in India, implementation of 
clinical pharmacy services helped in improving medication use at a South Indian 
teaching hospital.  India is a country with significant problems with medication use, 
but until recently Indian pharmacists have not been educated for a patient-care role. 
 Postgraduate pharmacy practice programs have been established at 2 pharmacy 
colleges in South India as a result of a joint Indo-Australian program of cooperation.  
At a teaching hospital associated with the colleges, clinical pharmacy services such as 
drug information, medication counseling, drug therapy review, adverse drug reaction 
reporting, and the preparation of antibiotic guidelines are assisting clinicians to 
improve drug therapy and patient care. 727 requests for drug information were 
received from July 1997 to February 2001, and 543 suspected adverse drug reactions 
were evaluated from November 1997 to February 2001. The most common drug 
classes causing adverse drug reactions were antibiotics, non steroidal anti-
inflammatory drugs, and anti tubercular agents. Physician opinion and service 
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utilization have also been surveyed: 82% of respondents had sought drug information 
from the Clinical Pharmacy Department and 71% of respondents had sought advice 
on individual patient management. The success of this program is  raising awareness 
of clinical pharmacy among pharmacy educators elsewhere in India and has led to the 
introduction of clinical pharmacy services at other Indian hospitals 
 ( Parthasarathi, et al. 2002). 
 
 
2.11.7  Implementing of Clinical Pharmacy Services in 
            Zimbabwe Pediatric hospital: 
 
Implementing of clinical pharmacy services has proved to optimize clinical care 
provided to patients. In Zimbabwe in 1998, there was a project of implementing 
clinical pharmacy services in one of it's central  hospitals which is Harare central 
hospital at the pediatric unit, the outcome was  motivating to implement such services 
in other hospitals. The pediatric department was the chosen department for 
implementing clinical pharmacy services.  In order to set up a clinical pharmacy 
services in the pediatric unit some basic requirements needed to be addressed. The 
chief pharmacist temporarily reorganized The available staff and designed the 
pediatric pharmacy team. The interventions made The available staff and designed the 
pediatric pharmacy team. The interventions made by the clinical pharmacists included 
provision of advices to nurses on IV administration, reinforcement and explanation of 
the   ``Essential Drug List of Zimbabwe`` to ensure adequate drugs, dosing and 
frequency prescribed in children, provision of advices on appropriate dosing 
according to renal and liver function, and on administration of oral doses from tablet 
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forms by crushing and dispensing when appropriate, if a liquid formulation is not 
available, making sure that the right parenteral route was used for the patient's age, for 
example IV is preferred rather than IM for neonates and provision of information for 
the patient about drug related issues while being on the ward. To evaluate the validity 
of services provided by clinical pharmacists a questionnaire was designed and 
distributed to nursing and medical staff 90%percent believed that pediatric pharmacy 
services was either good or excellent, 91% thought that the relationship between 
pharmacy/medical and nursing staff was improved due to better communication. 
The introduction of  pediatric pharmacy services was an excellent way to motivate the 
pharmacy staff at Harare Central Hospital. The staff was receptive to a potential 
change in practice and greatly appreciated having direct contact with patients, families 
and other professionals. This short project provided evidence of how simple, basic 
transfer of skills, without extensive financial donations, could make an impact on the 
quality of health services provided (Lopez, et al. 2002). 
 
2.11.8 Clinical pharmacy service provision in Australia—1998: 
 
The results of a 1998 national survey of clinical pharmacy services in hospitals 
throughout Australia showed that the five most commonly provided services were, 
informal drug education for hospital staff, review of medication charts, control of 
drug purchasing, and inpatient dispensing. Review of medication charts and provision 
of drug education for the hospital staff were the most widely provided clinical 
pharmacy services (Wilson, et al. 2000). 
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2.11.9  Clinical Pharmacy practice and education in the 
People's Republic of China-1993: 
 
There are two streams of medical practices in the People's Republic of China 
( PRC): traditional Chinese medicine and Western medicine. Hospital and 
community pharmacies are responsible for the dispensing of medicines used 
for both streams of medical practices. Forty-two colleges of pharmacy offer 
pharmacy education, half of which provide a Western medicine approach and 
the other half traditional Chinese medicine. Both types of colleges offer a 
four-year curriculum with options for specialization. Opportunities for 
graduate study are also available. Most of the graduates work in hospital 
pharmacies. Hospital pharmacies participate in the bulk manufacture of drugs 
and parenteral fluids. A bulk dispensing system is used by some hospitals; 
individual patient doses are dispensed in others. Recently, the need to develop 
clinical pharmacy services in PRC was recognized and training courses were 
begun. Curricula with specialization in clinical pharmacy are being considered 
by colleges of pharmacy (Lau, Chen, and Wang, 1993). 
 
2.11.10   Initiation of clinical pharmacy in Greece-1996:    
There was neither Clinical Pharmacy practice in Greece nor Hospital Formularies. 
Clinical Pharmacy (CP) services started experimentally during a 3-month period 
(February 1995-April 1995) at the 2nd surgical Department of "Apostle Paul-KAT" 
Hospitalin Athens. Since then there has been a strategy plan for further CP 
development. A study was conducted in 1996 to give information about these first 
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steps in introducing CP in Greece.  The work at the Department was based on the 
prescription monitoring of every patient, realizing the prescribing trends and giving 
priority to certain prescribing problems. Eventually there was a focus on antibiotics 
and respiratory system drugs. Clinical pharmacy services provided were: interventions 
for alternative drug treatment and the duration of antibiotic treatment,  interventions 
for individualization of drug dosage, monitoring adverse effects, discussions with 
patients about their drug treatment and educational presentations. The study revealed  
high acceptance by the medical staff. Comparison of 2 months (pre and post CP 
services) revealed 50.7% reduction in antibiotics and respiratory system drugs.  The 
results of the 1st experimental 3-month period are indicative for the consequences of 
CP services both for the quality of pharmaceutical care and pharmaco-economics 
(Stathoulopoulou,  Papastamatiou, and Lapidakis, 1996). 
2.11.11  An introductory course to facilitate the implementation of a 
clinical pharmacy programe in Iraq-1986: 
An introductory course in clinical pharmacy is discussed which is designed to 
implement the basic concepts of clinical pharmacy as well as assist in the stepwise 
transition from a pharmacy school, with primary emphasis on dispensing, to a more 
clinically (patient) oriented pharmacy program. The course is composed of a 2-h 
didactic session and a 3-h observation session per week for 3 months followed by 
daily 3-h practical clerkships for 4 months in the following areas: in-patient and out-
patient hospital pharmacy, clinical laboratory, internal medicine, pediatrics, surgery, 
and retail pharmacy. Weekly 2-hour discussion sessions at the college or site of the 
clerkship are scheduled to review these experiences and introduce additional topics 
such as patients rights, pharmacist-patient relations, and pharmacy relations with other 
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health professionals. This course promotes the development of a clinically oriented 
attitude in students and staff members in the college, and decreases the trauma of 
direct change from a product-oriented to a more patient-oriented curriculum 
(Ezzedeen,  et al.  1986). 
 
 
 
2.11.12 Determination of the drug information needs of the 
medical staff of a Nigerian hospital following implementation 
of clinical pharmacy services-1987: 
The types and frequency of questions asked of clinical pharmacists introducing 
clinical pharmacy services in the internal medicine wards of a Nigerian university 
hospital and the degree of compliance with pharmacists' recommendations were 
studied.  The most common type of drug information request concerned the presence 
or the likelihood of an adverse drug reaction. Continuous interaction between 
pharmacists and physicians in the patient-care setting results in a better appreciation 
of the pharmacist's role as drug information consultant, and the consequence of this is 
a high degree of compliance with pharmacists' recommendations (Ette, Achumba, and 
Brown-Awala, 19987). 
Although both the literature document the presence of effective clinical pharmacy 
services in a number of  hospitals across some countries, still patient-oriented services 
is slow to emerge on a consistent and visible basis.  The struggle to improve patient-
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oriented clinical pharmacy services will continue until hospital pharmacy managers 
and pharmacists evaluate their departments care carefully and reflect on how these 
departments are managed.  This is necessary for the successful implementation and 
delivery of clinical pharmacy services as a practice standard for pharmacy (Phillips, et 
al. 1987). 
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Chapter 3 
 
Conceptual Framework 
 
3.1 Conceptual Framework for Challenges of implementing clinical 
pharmacy services in Palestinian Governmental hospitals 
 
By reviewing the literature, the researcher found that many factors affect the 
effectiveness of implementing clinical pharmacy services not only in hospitals but 
also in any other health providing setting. Factors that appear likely to promote the 
wide distribution of clinical pharmacy services included opportunities to positively 
impact patients drug therapy outcome, expanded use of technology and technicians in 
the dispensing process, increased demand for drug information among health 
professionals and increased recognition of the need to impact clinical, economic, and 
humanistic patient outcomes. 
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Factors that appear likely to impair the adoption of new roles of pharmacists as 
clinical pharmacists and consequently will negatively impact the effectiveness of wide 
scale implementation of clinical pharmacy services included pharmacist-related 
barriers, practice-setting constrains, professional and administrative barriers and 
system related barriers. These factors are described by researchers, and details are 
mentioned in the literature review chapter. After collecting data and doing the 
necessary analysis the researcher will describe  these relevant factors which are 
considered important in affecting the effectiveness of implementing clinical pharmacy 
services in the Palestinian governmental hospitals. 
3.2 Conceptual framework (Diagram) 
Theoretical Diagram of Conceptual Framework 
 
 
 
 
 
 
 
 
 
 
 
 
Driving Forces 
Factors that affect the implementation of clinical 
pharmacy services 
 
Holding back forces 
Positively impact patient drug 
therapy outcome 
Pharmacist related barriers 
Positively impact patient's 
quality of life 
Practice setting constrains 
Positively impact health 
economic outcome 
Lack of consensus regarding 
the profession  
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Many factors can prompt and support the implementation of clinical pharmacy 
services.  With increased prescribing comes more frequently medication related 
problems which lead to significant health care problems associated with drug related 
morbidity and mortality.  The implementation of clinical pharmacy services will 
minimize such problems (ACCP, 2000). 
The direct involvement of a pharmacist throughout the medication use process helps 
ensure continuity of care and may minimize the risk, lower the cost, and improve the 
outcomes associated with drug therapy (Schumock, et al. 2000). 
Increased recognition of the need to impact clinical, economic, and humanistic patient 
outcome, pharmacists are well positioned to apply the scientific method effectively to 
outcome analysis. 
Clinical pharmacy services have been shown to identify drug related problems, reduce 
the incidence of clinically important drug related problems, improve patient education 
and compliance and improve clinical outcome. 
Pharmacists are often the health care professionals who have the greatest knowledge 
and skills to prevent, detect, monitor, and resolve drug-related problem. 
Support  the effectiveness and 
efficiency of wide scale 
implementation of clinical 
pharmacy services 
Hinder  the effectiveness and 
efficiency of wide scale 
implementation of clinical 
pharmacy services 
 
Expanded use of technology 
and technicians in the 
dispensing process 
 
Professional and 
administrative barriers  
 
Provision of drug information 
when needed 
System related barriers 
 89 
A variety of factors may impede pharmacists ability to implement clinical pharmacy 
services.  Individual pharmacist attitude and knowledge and skill deficiencies may 
hamper the implementation of clinical pharmacy services in any clinical pharmacy 
provided care in any practice setting. 
It is likely that some health care professionals will resist pharmacist's assumption of 
patient care role.  Physicians as a group may resist a pharmacist's taking a more 
reactive role in patient care.  Nurses too may view the presence of pharmacists on the 
unit as a threat (Poole, and Timothy, 2005). 
 
Administrations of most health care plans do not think that pharmacists can make 
contributions well beyond their traditional distributive duties (Raiford, Clarck, and 
Anderson, 1991). 
Resource constrains and other factors associated with a pharmaceutical practice are 
mentioned frequently as barriers to the provision of clinical pharmacy services 
(Deniso, 1986). 
A major system related barrier in health care settings is lack of a comprehensive, 
ongoing process for defining the appropriate outcomes of drug therapy.  Pharmacy 
departments create a barrier to the provision of clinical pharmacy services when they 
design organization chart.  Pharmacy managers lack sufficient time to plan for  the 
provision of clinical pharmacy  services and for an evolving patient centered practice 
(Louie and Robertson, 1993). 
The researcher considered the previous mentioned factors while designing the data 
collecting instrument and planning for the focus interviews. The factors are discussed 
in details in the literature review, these factors are not the only factors that may face 
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the implementation of clinical pharmacy services in the Palestinian Governmental  
hospitals.   
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Chapter 4 
 
Methodology 
 
This chapter will show the methods used to select the study design, sample, period of 
the study, place, data collection and data analysis. 
 
4.1 Study Design 
 
This is a qualitative descriptive study, it is based on the interpretation of data 
collected from key informant pharmacists who have knowledge that help in 
identifying factors that affect the implementation of clinical pharmacy services in the 
Palestinian Governmental Hospitals. 
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This type of study design is convenient for revealing and exploring the challenges that 
may face the implementation process, however the main disadvantage of this kind of 
study is in the interpretation and analysis of data collected which will be avoided by 
careful objective precise categorization of data obtained. 
 
4.2 Study population 
The study population included 25 key informants from MOH and  Al Azhar 
University. 
 
 
 
4.3 Study place 
 
The study was conducted in: 
1. General Administration of pharmacy (8 key informants). 
2. Pharmacy College at AL-Azhar university (2 key informants).  
3. Al- Shifa hospital in Gaza city (1 key informants).    
4. Gaza European hospital  in Khanyunis city  (4 key informants).   
5. Khanyunis hospital in Khanyunis city ( 2 key informants).   
6. Abu Usif Alnajar  hospital in Rafah  city (One key informant).  
7. Kamal Edwan  hospital  in Beet Lahea city (One key informant). 
8. Mohammad El Dorah hospital in Al Tefah area in Gaza city (One key 
informant). 
9. Shuhada El Aqsa  hospital in Deer Al Balah  city (One key informant). 
10. Al Nasser hospital in Gaza city (three key informants). 
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11. Al Oyoon  hospital in Gaza city (one key informant). 
 
4.4 study period 
 
Time line of this study was nine months from February 2005 to October 2005. 
The administrative procedures including MOH authorization took place at the 
beginning of February 2004.  Data collection started from May 2005 to July  2005. 
 
4.5   Sample Size 
The sample included 25 key informant were interviewed  for their knowledge and 
expertise. 
4.6  Sampling 
It is a non probability purposive sample. 
 
4.7   Eligibility Criteria 
Inclusion criteria 
Pharmacists who have professional education in clinical pharmacy science or, 
administrative clinical pharmacy knowledge or have practical experience of two 
months or more.  
Exclusion criteria 
 Pharmacists who do not have a professional educational diploma in clinical 
pharmacy or, 
 Pharmacists who do not have administrative knowledge or, 
 Pharmacists with practical experience of less than two months. 
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4.8  Data Collection 
 
Loosely structured  questions, Focus  interviews were  conducted. 
The researcher interviewed all the target sample, interview time ranged from 35 
minutes to 60 minutes. The over all time needed to collect the data was two months 
from May 5, 2005 to July 5, 2005, it took two months instead of one month because 
of the traveling obstacles faced the researcher before the disengagement took place, 
and because some interviewers were abroad or too busy to conduct the interview 
(annex 1). 
 
4.9 Response rate 
 
The response rate in this study was 100%, all selected key informants agreed to 
participate in the study.  This indicates their interest in the topic to be researched.   
 
4.10  Validity of the instrument 
 
Content validity of the instrument used for data collection in this study by discussing 
the instrument with expert committee included two public health experts and, six 
expert pharmacists, as a result, some items were added, modified or neglected. 
 
4.11    Ethical Matter 
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An official letter of request was obtained from the MOH director general to conduct 
the study in the General Administration of Pharmacy (annex 11), and College of 
Pharmacy at Al _Azhar University(annex 12), and an official letter of approval was 
obtained from the Helsinki committee (annex 13). 
Each participant was given an explanatory letter which was given before conducting 
the interview (annex 15). 
 
 
 
 
 
4.12 Data Analysis 
 
Data were entered and analyzed using manual open coding thematically analysis. 
Data analysis contained different stages as follow: 
1- preparation of interview summary sheet at the end of each interview 
2- descriptive codes was made which involved a systematic recording of data 
3- categorization of  the codes obtained 
4- presentation of data by visual displays such as boxes. 
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Chapter 5 
 
Results 
 
5.1 Executive Summary 
 
 There was divergent points of views considering holding back forces and 
driving forces that constitute the various challenges facing the implementation  
of clinical pharmacy services in the Palestinian Governmental Hospitals. 
 All key informants agreed that creating clinical pharmacist from traditional 
pharmacist is considered the main challenge that need more attention and 
consideration. 
 Intra professional barriers is considered one of the obstacles that need to be 
overcame in order to get to a better outcome regarding clinical pharmacy. 
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 Administrative issues and governmental support is one of the key factors that 
affect the implementation process either negatively or positively. 
 Key informants had many important points and recommendations that help in 
recognizing many areas that strengthens the implementation process and make 
it more efficient and effective. 
 18 of key informants  believed that holding back forces could be potential 
driving forces if wisdom and careful decision are taken.   
 
 
 
5.2   Description of Driving Forces that face the implementation 
process 
 
There is  a consensus between key informants to consider benefits of clinical 
pharmacy services as driving forces that support  the implementation process.  
Wide range of benefits are gained by implementing clinical pharmacy services.  
Clinical pharmacy is very important in many aspects that make it a very good 
profession to adopt.  Economic efficiency and improving quality of patient life are 
considered of the aspects of clinical pharmacy advantages. 
 
5.2.1   Improvement of quality of patient life: 
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All  Key informants assured that  clinical pharmacy improve the quality of patients 
life is considered one of the most driving forces that support it's implementation in the 
hospitals. 
 
…Clinical pharmacy profession help in improving the quality of patient life by 
looking for possible drug interactions, appropriate drug regimen. 
It is the profession that minimize medical errors that are lethal in many situations 
and threats patient life, this is one of the driving forces that makes the 
implementation of clinical pharmacy services in our  hospitals a necessity. 
-clinical pharmacy lecturer- Al Azhar university 
 
 
…Minimizing  medication error that may result from drug interaction with other 
drug or food, or from incorrect prescription, preparation and/or administration 
medicine is considered one of the main benefits of clinical pharmacy which 
encourage us to proceed and keep going towards the full implementation of this  
profession in our hospitals. 
-General Director of Pharmacy- 
 
The ways by which clinical pharmacy services can improve patient's quality of life (as 
revealed by key informants) can be summarized as follows: 
 Avoidance of drug interactions with other drugs and food taken. 
 Minimizing medication error that may result from incorrect prescription, 
dispensing, preparation and/or administration of medicine 
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 provision of medical information that increase patient compliance and 
promote correct use of medicine. 
 
Table 5.1 shows how clinical pharmacy services can improve the quality of patients 
life as revealed by key informants. 
 
 
 
 
 
 
 
Table 5.1: clinical pharmacy services that can improve patients and considered 
of the driving forces of the implementation process as revealed by the 25 key 
informants 
 
 
Clinical pharmacy service provided 
that improve quality of patient medical 
care (driving force) 
 
 
 
Key informants 
Avoidance of drug interactions with other 
drugs and food taken. 
25 
Minimizing medication error that may 
result from incorrect prescription, 
25 
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dispensing, preparation and/or 
administration of medicine 
Knowledge of patient medical history and 
avoidance of unnecessary 
hypersensitivity reactions  
24 
provision of medical information that 
increase patient compliance and promote 
correct use of medicine 
23 
 
 
 
 
5.2.2  Economic efficiency gained by implementing clinical pharmacy 
Services: 
 
All respondents acknowledged a link between implementation of clinical pharmacy 
services and economic efficiency. 
…Clinical pharmacy is implemented in many developed countries for its various 
benefits and good outcomes, economic efficiency is one of its benefits that  
encourage  many countries to adopt it in their hospitals. 
-General director of pharmacy- 
 
The ways by which clinical pharmacy services can assure economic efficiency (as 
revealed by key informants) can be summarized as follows: 
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 Decrease patient hospitalization time by assuring good prescription, 
preparation and administration of drugs. 
 Elimination of drug waste and duplication by provision of proper drug 
management. 
 Minimizing medication errors that result from variety of causes. 
 Assuring that the essential drug list is used properly and effectively in treating 
patients, and no drugs are expired without getting the maximum benefit of it. 
 
Table 5.2 shows how clinical pharmacy services can assure economic efficiency as 
revealed by key informants. 
 
 
 
Table 5.2:  Economic efficiency gained by implementing clinical pharmacy 
services.  
 
 
Clinical pharmacy service provided 
that assure economic efficiency  
(driving force) 
 
 
 
Key informants 
Decrease patient hospitalization time by 
assuring good prescription, preparation 
and administration of drugs 
23 
Elimination  of drug waste and 25 
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duplication by provision of proper drug 
management  
Minimizing medication errors that result 
from variety of causes 
25 
Assurance that the essential drug list is 
used properly and effectively in treating 
patients, and no drugs are expired without 
getting the maximum benefit of it 
23 
 
 
 
 
5.2.3 Provision of an ideal medical team work: 
 
All key informants revealed that medical team work is the best approach that ensure 
effective medical work, clinical pharmacist is one of the medical team members who 
will interact with both physicians and nurses and exchange medical information with 
them, this will maximize the benefits of medical service provided. 
 
… Presence of the clinical pharmacist with the medical team during the morning 
meeting and the medical round will allow more medical information exchange 
between the physician and the pharmacist regarding the best drug to be prescribed 
and the proper dose and regimen, it is also very challenging for the pharmacist to 
read more and to improve his medical skills day by day.   
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Dean of  Pharmacy College- Al-Azhar university 
 
…By interacting with physicians and nurses clinical pharmacist will gain more 
knowledge and expertise, in the same time he/she will provide medical 
information on the spot, this will be very helpful in many situations. 
Pharmaceutical quality improvement committee member 
 
25 of key informants revealed that the presence of the clinical pharmacist with the 
medical team will allow on the spot information regarding availability of the drug in 
the pharmacy or in the medical stores, about proper preparation and reconstitution of 
drugs and the best time and route of administration, nurses will get  medical 
information immediately, also physicians will get information that will help them in 
prescribing the available drugs to cover the time course needed for treatment. 
…Presence of the clinical pharmacist with the medical team will bridge the gap 
between the hospital pharmacy and different  hospital departments regarding the 
presence of drugs in the medical store either in the central pharmacy stores or in 
the central drug stores in Gaza.  In many times we had to make some 
modifications in types of drugs requested by different hospital departments 
because the drug is not available or the quantity is not sufficient or limited. 
- Vise general pharmacy director- 
 
…While being with the medical team, clinical pharmacist will find himself in a 
very challenging situation, he/she must be able to communicate with the medical 
team members, answering their questions regarding medical information about 
drugs. 
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 This will make her/him read more and know more, in the same time the physician 
will reconsider many factors while prescribing and deciding whether to continue 
therapy or not.  One of these factors is  the information provided by the clinical 
pharmacist, this will allow maximum health information exchange between 
different members of the medical team. 
          -Director of hospital pharmacies- 
 
… By being in the medical round with the medical team (physicians and nurses)  
information could be provided about availability of the antibiotic "Rocephin" each      
time the physician wanted to prescribe it.  In the past many patient took Rocephin 
then the antibiotic course was not completed because the antibiotic was not 
available any more.  I think this kind of intervention is very vital in assuring the 
safety of the patient  and will lead to minimizing drug waste which is very 
essential for our health economy. 
-In  Practice clinical pharmacist, pediatric department- 
 
 
  … In the  first time I went to the nurse station to see how drug is prepared , I 
noticed that penicillin is prepared for 24 hours stability time, which was 
scientifically wrong, I spoke friendly with the nurses and provided medical 
information about the proper    way of reconstitution of the antibiotic and that it 
should be discarded after being reconstituted. 
-In practice clinical pharmacist- 
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The ways by which the presence of clinical pharmacist can optimize the medical care 
provided by the medical team, can be summarized as follows: 
 Optimizing  health information exchange between different members of the 
medical team. 
 Provision of on spot medical information about the availability of the drug in 
the medical store (for physicians).  
 Provide on spot information about the right way of preparing, reconstituting 
discarding or keeping the drug and storing it (for nurses). 
 The clinical pharmacist will be the link between the pharmacy medical store 
and the department he/she works in, this will inform the pharmacy about  
drugs needed urgently in order to provide it to the medical department and 
about drugs that are not present in the essential drug list and need to be 
provided. 
Table 5. 3:   Clinical pharmacy services can  optimize medical care obtained by 
the spirit of medical team. 
 
The ways by which the presence of 
clinical pharmacist can optimize the 
 medical care provided by the medical 
team  (driving force) 
 
 
Key informants 
Will allow maximum  health information 
exchange between different members of 
the medical team 
25 
Provision of on spot medical information 
about the availability of the drug in the 
 
25 
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medical store (for physicians) 
Provide on spot information about the 
right way of preparing, reconstituting, 
discarding or keeping the drug and 
storing it (for nurses)  
 
24 
The clinical pharmacist will be the link 
between the pharmacy medical store and 
the department he works in, this will 
inform the pharmacy about  drugs needed 
urgently in order to provide it to the 
medical department and about drugs that 
are not present in the essential drug list 
and need to be provided  
 
 
 
24 
5.2.4 Clinical Pharmacy is important for the profession of 
Pharmacy: 
 
24 key informants revealed that most hospital pharmacists work as drug dispensers, 
the thing which does not fit the knowledge they have. 
 
… Why should the pharmacist study  pathology, physiology and different 
pharmaceutical sciences if his only duty is to act as drug dispenser and drug guard 
keeper. 
                     -Chief pharmacist of the European hospital pharmacy- 
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Presence of clinical pharmacy specialization is important to the profession of 
pharmacy because it leads to: 
 Increasing the knowledge and expertise of the pharmacist. 
 Maximizes the benefit obtained by the pharmacists knowledge by practicing 
what was learned. 
 Increase self esteem and improve self concept of the pharmacist. 
 
Table 5.4 shows how clinical pharmacy services are important to the profession of 
pharmacy as revealed by key informants. 
 
 
 
 
 
Table 5.4:   Clinical pharmacy services is important to the profession of 
pharmacy 
  
 
The ways by which clinical pharmacy  
is important to the profession of 
pharmacy: 
 
 
Key informants 
 Increase the knowledge and expertise of 
the pharmacist 
25 
Give the maximum benefit obtained by 
the pharmacist's knowledge, by practicing 
 
24 
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what was learned theoretically   
Increase self esteem and improve self 
concept of the pharmacist 
 
18 
 
5.2.5  Presence of Pharmaceutical Quality Improvement Committee: 
 
24  key informants acknowledged the presence of Pharmaceutical Quality 
Improvement Committee, that proposed the implementation of clinical pharmacy 
services in Gaza Strip governmental hospitals from the beginning.  They considered it 
as one of the major driving forces that should be empowered and supported. 
The researcher asked the key informants about the ways this committee supported or 
could support the profession of clinical pharmacy,  the  following answers were 
obtained: 
1- Management of clinical pharmacy services. 
2- Evaluation  of performance of clinical pharmacists. 
 
3- Evaluation of  clinical pharmacy economic outcome. 
4- Provision of training courses to clinical pharmacists. 
5- Provision of detailed guideline that regulate the relationship between 
the clinical pharmacist and the medical staff members. 
6- Provision of job description that helped in understanding the nature of 
the work of the clinical pharmacist. 
 
5.2.6 Development  of the curricula of pharmacy college at Al-Azhar 
University, and increasing number of pharmacy graduates: 
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All key informants considered development of pharmacy college curricula as driving 
force that will help in the future preparation of clinical pharmacists.  The increasing 
number of pharmacy graduates will provide more and more manpower that support 
the trend regarding implementing clinical pharmacy services.  
  
…introducing  clinical pharmacy courses in the curricula of pharmacy college will 
help greatly in introducing the new concept to the pharmacy graduates and will 
help in preparing future competent clinical pharmacists. 
                    -Director of General Administration of pharmacy- 
 
 
 
 
5.2.7 Well and Desire of the selected pharmacists to act as clinical 
pharmacists: 
 
20  key informants considered the well and desire of the selected hospital pharmacists 
to act as clinical pharmacists as driving force that help in the effective implementation 
of clinical pharmacy services. 
 
…selection of the pharmacists to act as clinical pharmacists was based on their 
well, desire and interests to act as clinical pharmacists.  Their determination to act 
as clinical pharmacists will soften many obstacles that may be found during the 
implementation process. 
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                            -Chief pharmacist of Pharmacy Inspection Department- 
 
Driving forces that support the implementation of clinical pharmacy services could be 
summarized as follows: 
1- Improvement of quality of patient life. 
2- Economic efficiency gained by implementing clinical pharmacy Services.  
3- Provision of an ideal medical team work. 
4-  Clinical Pharmacy is important for the profession of  Pharmacy. 
5-  Presence of Pharmaceutical Quality Improvement Committee. 
6- Development of the curricula of pharmacy college at Al-Azha University, and     
increasing number of pharmacy graduates. 
7- Well and Desire of the selected pharmacists to act as clinical pharmacists. 
 
 
5.3 Description of Holding Back  Forces that faced or may Face the 
          Implementation Process 
Key informants had wide points of views  regarding the main holding forces that may 
affect the implementation process in a negative way. 
 
5.3.1 In practice clinical pharmacy staff  knowledge, experience  and 
            communication skills factors: 
 
24 of key informants revealed that lack of special training courses and specialized 
academic degrees is one of the challenges that face the effectiveness of the 
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implementation process.  The 24 key informants revealed that  lack of specialized 
scientific and communication training courses could negatively affect the 
implementation process by the following ways: 
1- Ineffective communication between clinical pharmacists and other 
medical team members. 
2- Lack of ability to deal with the required information on the best time 
and manner. 
3- Misconception of the role of the clinical pharmacist by health 
providers due to inability of the pharmacist to communicate in a good 
manner.  
4- Lack of training courses will lower self confidence, self image, and 
will create different goals and attitudes regarding clinical pharmacy 
profession. 
 
…In practice clinical pharmacists were chosen on basis of their well and desire to 
act as clinical pharmacists, they did not get any training courses.  They are only 
Bachelor degree holder, non of them have advanced academic degree, neither in 
clinical science nor in  any specialized training courses in clinical pharmacy, We 
have to consider this point deeply when speaking about clinical pharmacy. 
-The manager of hospital pharmacists- 
 
…The biggest challenge of  implementing clinical pharmacy services is creating a 
clinical pharmacist from a bachelor degree pharmacist who had no previous 
training courses nor specialized degree in clinical pharmacy science 
-pharmaceutical quality improvement committee member- 
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…sometimes the patient asks me about the nature of his/her  disease, I feel so afraid 
to tell, I think there is no standards for what to tell and what to keep out. 
                     - In practice clinical pharmacist in  oncology department- 
 
… In practice clinical pharmacist has no previous knowledge about what to say or 
about what not to say,  either to patients or to their relatives.  They did not get 
special communication skills, or training courses that enable them to deal with 
medical team members or with the patients, and that’s why the first 
recommendation that was given to the pharmacists is to observe only and not  to 
provide any information to any patient.  Just keep observing and asking for more 
information. 
-pharmaceutical quality improvement committee member- 
 
5.3.2   Lack of mentality regarding the profession of clinical 
             Pharmacy: 
 
25 key informants revealed that absence of mentality regarding the nature of the 
profession of clinical pharmacy is the main holding back force that my negatively 
affect the implementation process.  All key informants revealed that this lack of 
mentality is due to two main factors: 
 
1- No information culture regarding the profession of clinical pharmacy 
2- Lack of philosophy that regulate the whole clinical pharmacy discipline. 
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…All medical field workers have their perception and knowledge about the 
medical role about different field workers job.  For example the physician is the 
one who diagnoses the disease and prescribes treatment, the nurse is the one who 
prepares drugs and administers it to the patient, the pharmacist is the one who 
dispense drugs.  But what is a clinical pharmacist and why there is a need for such 
profession? 
This question will be always asked not only by nurses, physicians and other field 
workers but also by ordinary people who may be in contact with the clinical 
pharmacist. 
-Director of General Administration of Pharmacy- 
…When I was in the medical round that day,  a physician asked me about my 
profession.  Then I had to answer many questions regarding clinical pharmacy 
profession. 
-in practice clinical pharmacist in the medical male department- 
5.3.1 Administrational changes that stopped a system wide   
implementation of clinical pharmacy: 
 
24 key informants believed that administer changes is a  serious holding back force 
that hinder the  effective implementation of clinical pharmacy services. 
On Aug 1, 2005, there was a minstry decision that refers all hospital pharmacists and 
primary health care centers pharmacists to the managers of these hospitals and 
primary care centers.  The general administration of pharmacy would have no 
authority over these pharmacists any more ( Annex  9). 
24 of key informants insisted that this decision negatively affected the clinical 
pharmacists who have worked in the hospitals.  The pharmaceutical Quality 
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Improvement committee could not follow up those pharmacists, it could not support 
their function in any direction. 
 
  …All the world is moving towards specialization, we are the only ones  moving  
toward more centralism. 
-General Director of Pharmacy- 
…The decision was  very humiliating.  It was a big surprise to us.  The decision 
was unidirectional , there was no consultation for the sake of the quality of  health 
care. 
-Pharmaceutical quality improvement committee- 
 
Whether that decision was a good one or not is not the issue the researcher is 
discussing here, the issue is to explore how did that decision affect clinical pharmacy 
implementation process. 
 
... this was the gun shot directed to the head of clinical pharmacy 
implementation process, since that date we did not hear from the pharmacy 
department.  No one provided us with references nor new directions.  No 
training courses in clinical pharmacy nor in communication skills. we feel  like 
left alone and with something that is totally new for us. 
                                         -In practice clinical pharmacists- 
 
5.3.4  lack of follow up and evaluation: 
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25 key informants revealed that there is lack of follow up and evaluation, this is 
because absence of logistic support provided by MOH.   
…for three months we could not have any communication with in practice 
clinical pharmacists who work in the hospitals,  this is because of the ministry 
decision that refers these pharmacists not to the General Administration of 
pharmacy, but to the directors of the hospitals they are working in. 
-Director of Pharmaceutical Quality Improvement committee- 
 
…we did not hear any thing from the General Administration of pharmacy for 
more than two and half months, we are just left alone, I do not work as clinical 
pharmacist anymore, now I work as drug dispenser in the ward pharmacy. 
-in practice clinical pharmacist- 
 
 
 
5.3.5  Intra-professional barriers: 
       
23 key informants revealed that inter professional barriers is a major obstacle to 
 face and handle during the implementation process, these barriers exist between the 
clinical pharmacist and other medical field workers like physicians and nurses.  They 
added that such barriers may exist between the clinical pharmacist and his/her 
colleagues.  
 
 Clinical Pharmacist –Physician relationship 
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…The traditional role of the pharmacist is to prepare and dispense drugs.  To 
have a pharmacist  interfering in the process of  drug prescribing  is perceived 
by the physician as something wrong.  
It is normal for the physician to have many questions regarding the nature of the  
profession of clinical pharmacy, but things must be clear that the role of the 
clinical  pharmacist is a complementary.  
-Chief pharmacist of Pharmacy Inspection Department- 
 
 Clinical Pharmacist- Nurse relationship 
 
…Nurses are used to their job in preparing and administrating drugs to patients.  
When someone come to tell them that their preparation and administration 
method need more attention and accuracy, they will not feel good about that,  
and will think that the clinical pharmacist is interfering in their own duties. 
-Member of the pharmaceutical  quality improvement committee- 
 
   … In the medical male department nurses used the same reconstituted vial for  
24 hours stability time, when I told them friendly that this is not correct and that 
the remaining quantity should be discarded immediately after use, they replied 
they  are doing the right thing to be done, that's because the quantity of the drug 
is scarce and not always available. 
               -In practice clinical pharmacist at the internal medicine department- 
 
 Clinical Pharmacist- Ward Pharmacist relationship 
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When the researcher asked key informants about the expected barriers between 
clinical pharmacists and their colleagues who are  ward hospital pharmacists, 
key informants revealed that traditional pharmacists do not have enough 
knowledge about the importance of the implementation of clinical pharmacy 
services, this lead to underestimation of the role of the clinical pharmacist.  
 
… I like the profession of clinical pharmacy, but sometimes I get annoyed and 
frustrated about my colleagues underestimating comments.  
-In practice clinical pharmacists- 
 
5.3.2 Lack of Resources and references:  
 
24 key informants insisted about  the importance of presence of updated references in 
order to get updated information and knowledge. They insisted the importance of 
presence of resources in order to provide such references and to publish periodicals 
that express the nature of  clinical pharmacy services to other medical field workers. 
 
…Most of the hospitals have net connection but unfortunately the accessibility to 
the service is not applicable to the pharmacists. 
-Chief pharmacist of pharmacy licensing department- 
 
…We do not have any references here.  When I need to check for any medical 
information, I usually refer to the books I studied in the Pharmacy College. 
-In practice clinical pharmacist- 
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5.3.3 work force and manpower: 
 
24 key informants revealed that the number of clinical pharmacists proposed to 
implement clinical pharmacy services is very small, and the required number is two 
pharmacists for each department in the hospital, but to start is better than not to start.  
 
5.3.4 Work place and working environment: 
 
15 key informants revealed that there is no suitable workplace nor working 
environment to enable the clinical pharmacist to do his/her work. 
 
…One of the duties of clinical pharmacist is to fill special reports about each 
patient case, and to search for the suitability of drug prescribed to the diagnosis 
made. 
 Some pharmacists make their research work in the hospital pharmacy department, 
where other activities in dispensing and monitoring quantity activities are made. 
Others stay in the physicians room, or move from one department to another, there 
is no suitable working environment supporting clinical pharmacist activities. 
-Member of pharmaceutical quality improvement committee- 
 
  …There is no specific place for me as a clinical pharmacist, sometimes I will sit in  
the physician room after the morning round.   Other times,  I go to the pharmacy to 
participate in dispensing. There is no place for further reading and  no place to locate 
my books and stuff. 
-In practice clinical pharmacist- 
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…The place of the clinical pharmacist is in the pharmacy, he should share in in 
dispensing in addition to his clinical pharmacy duties. 
-Chief pharmacist of Gaza European hospital pharmacy- 
 
…How could I act as a medical information provider , if there is no time, place to 
read, or to make researches.  
-In practice clinical pharmacist- 
 
  …The hospital pharmacy has limited space for the three hospital pharmacists that 
already exists.  When they move they have big difficulties in avoiding crashing to one 
another.  I want you to come and see the hospital pharmacy in the medical 
department. 
-In practice clinical pharmacist- 
5.3.9   Lack of Rewards and Motivation: 
 
20  key informants  revealed that absence of rewards and motivations may lead to 
frustration, job burnout and eventually to turnover.  
 
…In practice clinical pharmacist has many duties to do, many reports to fill, many  
questions to answer and, there must be some sort of motivation to keep them in their 
full  capacity and energy. 
                    -Member of the pharmaceutical  quality improvement committee- 
 
5.3.10  Time Constrains and Workload: 
 121 
 
15 key informants believed that in practice clinical pharmacists will experience  time 
constrains  and  heavy workload , this may contribute to ineffectiveness in providing 
clinical pharmacy services. 
Pharmacists who are selected to act as clinical pharmacists have to do about 11 duties  
every day according to the Job description, in the same time and according to 
Pharmaceutical Quality Improvement committee members, these pharmacists should 
participate in the dispensing process in the ward pharmacy and make sure that  
quantity of drug is maintained  in its legal level. 
…The job description provided to us as in practice clinical pharmacists did not 
mention that we have two jobs, one of them to provide clinical pharmacy services 
and the other to work as ward pharmacists, I really find this thing very confusing, 
I do not know exactly which job should I perform. 
-in practice clinical pharmacist- 
Table 5.5:  holding back forces that affect the implementation process as 
revealed by key informants. 
 
 
holding back forces that affect the 
implementation process as revealed by 
key informants: 
 
 
 
Key informants 
Lack of mentality regarding the 
profession 
 
 
25 
Lack of follow up and evaluation 25 
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Administrational changes and instability  
24 
Insufficient work force and manpower 
 
24 
Lack of resources and references 
 
24 
Lack of specialized scientific and 
communication training courses 
 
24 
Intra professional barriers 
 
23 
Lack of rewards and motivation 
 
20 
Inappropriate work place and  working 
environment 
 
15 
Time constrains and heavy workload 15 
 
Table 5.6: summary of driving forces and holding back forces that affect the 
implementation process as revealed by key informants. 
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Driving forces as revealed by key 
informants 
1- improvement of quality of 
patient life 
 provision of medical information 
 avoidance of drug interactions  
 taking patient medical history ,  
             hypersensitivity reactions. 
 minimizing medication error 
 
2- Economic efficiency 
 Decrease patient hospitalization 
time  
 elimination of drug waste and 
      duplication by provision of proper    
drug management 
 minimizing medication errors  
 assurance that essential drug list is 
used 
 
 
Driving forces as revealed by key 
informants 
3- provision of an ideal team work 
 
Holding back forces as revealed by key 
informants 
1- Lack of mentality regarding the 
profession of clinical pharmacy 
 No information culture 
regarding the profession of 
clinical pharmacy 
 Lack of philosophy that 
regulate the whole clinical 
pharmacy discipline. 
 
2- Administrational changes and 
instability 
 Many changes that hinder the 
effectiveness of the 
implementation process 
        3- Insufficient workforce and 
           Manpower. 
4- Lack of resources and reference. 
 
 
Holding back forces as revealed by key 
informants 
5-lack of specialized scientific and 
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 will allow max. health 
information exchange. 
 Provision of on spot information 
about drug availability 
4- new step towards  pharmacy 
profession 
 increase knowledge and 
expertise of the pharmacist. 
 Give the maximum benefit 
obtained by the pharmacists 
knowledge, by practicing what 
he/she learned in the 
pharmacy college. 
 Increase self esteem and 
improve self concept of the 
pharmacist  
5- well and desire of  selected 
clinical pharmacists to act as 
clinical pharmacists. 
 
 
 
Driving forces as revealed by key 
informants 
 
      communication skills training 
       courses. 
 Ineffective communication 
between clinical pharmacist and 
other medical team members. 
 Lack of ability to deal with the 
required information on the best 
time and manner. 
 Misconception of the role of the 
clinical pharmacist by health 
providers due to inability of the 
pharmacist to communicate in a 
good manner  
6 – Intra professional barriers 
 Clinical pharmacist- physician  
 Clinical pharmacist- 
pharmacist 
 Clinical pharmacist- nurse 
 
 
 
 
Holding back forces as revealed by key 
informants 
 
 125 
6- Presence of pharmaceutical 
quality improvement committee, 
that monitor clinical pharmacists 
performance and services 
provided. 
7- Development of pharmacy college 
curricula and increased number of 
pharmacy graduates.  
7-Lack of rewards and motivation 
 
8-Inappropriate work place and  
working environment 
 
9-Time constrains and  heavy 
workload. 
10- lack of follow up and evaluation. 
 
Implementing clinical pharmacy services in Gaza Strip governmental hospitals is very 
important for improving patients quality of life, medicine cost efficiency, and for the 
profession of pharmacy. Many factors affect the implementation process either 
positively ( Driving Forces) or negatively ( holding back forces).  Key informants had 
their knowledge and expectations regarding the potent influence of these factors on 
the effectiveness of the implementation process.  There is so much to be  done in 
order to get the maximum benefits of the diving factors that support, encourage and 
motivate the effectiveness of the implementation of such services, and to avoid the 
negative impact of the holding back factors that may suppress, hinder and/or stop the 
process. 
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5.11  The impact of clinical pharmacy implementation  on  patients` 
life quality and health economy-(Driving Force) 
 
25  Key informants assured that  clinical pharmacy improve the quality of patients life 
is considered one of the most driving forces that support it's implementation in the 
hospitals. 
With increased prescribing,  comes more frequent medication-related problems  major 
area for pharmacist intervention, through the past 30 years numerous publications 
have detailed significant health care problems associated with drug related morbidity 
and mortality, for each 1$ spent on medications in nursing homes, 1.33$ is expended 
for drug related problems, so clinical services have a positive impact on  both patient 
outcomes and health care costs (ACCP, 2000). 
Clinical pharmacists job description proposed by Pharmaceutical Quality 
Improvement Committee,  regulates and guide clinical pharmacy duties to be  
perfumed.  It stated that the pharmacist should  participate with medical team 
members in the physician round , study and document  the medical history of the 
patient, patient follow up and monitoring drug compliance, and  monitor drug 
prescriptions for possible interactions and suggestion of alternative drug choices if 
such interaction exists. 
Key informants revealed that clinical pharmacy services are patient-centered and aim 
at maximizing health care provided to patients.  If such activities are performed 
correctly and honestly,  it in turn will  have a direct positive impact on the patient's 
quality of life. In this case,  implementation of clinical pharmacy services will  
become more and more adopted by different administrations.  If clinical pharmacy 
services is  performed as suggested by the Pharmaceutical Quality Improvement 
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Committee both correctly and efficiently, then direct positive economic outcome will 
be achieved through reduction of medication error, hospitalization time and drug and 
disease management.  
5.12   The impact of clinical pharmacy implementation on   
          health  team work (Driving Force) 
 
All key informants revealed that medical team work is the best approach that ensure 
effective medical work, it optimize medical information, knowledge and expertise 
exchange between health team members. 
Clinical pharmacist is an essential member of the health care team and he/she should 
cooperate with physicians, nurses and other health care professionals to optimize 
patients drug therapy (ACCP, 2000).  The principles of practice for an integrated  
clinical pharmacy  approach demonstrate the knowledge required for a pharmacist and 
the level to which the pharmacist must participate with other health-care professional 
in order to provide the best care. Health care professionals always will need current 
information about new drugs, devices, and medical advances, particularly in view of 
the rapid pace of new drug development and clinical pharmacists would be the main 
providers of such information (Al-Shaqha and Zairi, 2001). 
According to key informants opinions and recommendations regarding optimizing 
team work, they suggested that there is a need for workshops in order to understand 
the clinical pharmacy concept better. There was consensus that  presence of the 
clinical pharmacist with the health team members will  make him/her a good source of  
information , for example provision of  information about availability of drugs in the 
local drug store.  This will help the physician to restrict prescribing to available drugs, 
and will help  nurses to prepare  the appropriate  medical request and deliver it to the 
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pharmacy ward.  This thing  will   insure  saving time and effort for the sake of the 
patient. Pharmacists will gain much expertise and knowledge concerning the disease 
nature, and management when he/she participate in the medical round and morning 
meeting.  Such interchange of medical information among members of the health 
team and the clinical pharmacy staff members will be a driving force that support the 
effectiveness of the clinical services to be delivered. 
  
5.13  The impact of clinical pharmacy implementation on pharmacy 
          Profession (Driving Force) 
  
Pharmacy is the only health care profession that is reimbursed primarily through sale 
of a product rather than for provision of patient- specific service.  Reimbursement of 
pharmacists for direct patient care services unrelated to the distribution of a product is 
now occurring, and concerted efforts to increase the number of pharmacists able to 
successfully secure this compensation are under way (ACCP, 2002). 
24 key informants revealed that implementing clinical pharmacy services is a good 
step towards renovation of pharmacy profession, they had a consensus regarding that 
for pharmacists to work mainly  as drug dispensers and  drug guard keepers  will 
humiliate their intellectual power and personal abilities. Implementation of such 
services will save the pharmacists from experiencing this work life long painful 
experience. Hospital pharmacists  have the knowledge and expertise to practice 
clinical pharmacy services if they  get  the appropriate training. 
 The selected pharmacists revealed that they liked to work as clinical pharmacists 
because they could not endure counting pills and capsules in the time they feel 
themselves capable of doing more than this. This implementation will make other 
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health care providers reconsider their perception about pharmacists`  critical role in 
disease and drug management and improving patients` quality of life. 
 
 
5.14 Presence of Pharmaceutical Quality Improvement Committee   
      (Driving Force) 
 
24  key informants acknowledged the presence of Pharmaceutical Quality 
Improvement Committee, that proposed the implementation of clinical pharmacy 
services in Gaza Strip governmental hospitals from the beginning.  They considered it 
as one of the major driving forces that should be empowered and supported.  This 
committee is considered by key informants to be the nucleus of future clinical 
pharmacy administration and management discipline, that will monitor, follow up and 
evaluate clinical pharmacy services. 
For many health systems around the world, clinical pharmacy administration emerged 
as a separate discipline.  It is an applied field of study that deals with the research, 
evaluation and management of the patient, the drug, and the clinical practitioner as 
they relate to patient care (Einarson, 1988). 
General administration of pharmacy and through it's pharmaceutical quality 
improvement committee played a vital role in order to start the implementation of 
clinical services in some of MOH hospitals.  They attained the official approval  from 
MOH.  The pharmacists  were to start working as clinical pharmacists, and were given 
special orientation course about clinical pharmacy activities. 
Despite the efforts of the Pharmaceutical Quality Improvement Committee there is 
much still to be said and done about the issue. For more than three consecutive 
 130 
months,  in practice pharmacists were left alone without follow up or evaluation.  No 
directions nor references were given to them, they are just left behind.  These  events 
lead many in- practice clinical pharmacists reconsider their decision about clinical 
pharmacy training. After asking the  Pharmaceutical Quality Improvement Committee 
Director about the causes of such absence,  he replied that there is no authority  given 
to them as a committee  to monitor , follow up and evaluate the hospital pharmacists 
after the decision of the Ministry of Health to refer hospital pharmacists to the 
managers of the hospitals.  
This brings us to the importance of making Clinical Pharmacy department as a 
separate discipline that has the freedom , power of law and authority to organize the 
clinical pharmacy services and direct it's activities.  This approach should be 
supported and empowered by MOH in order for the implementation process to 
succeed. 
24 Key informants revealed that presence of Pharmaceutical Quality improvement 
Committee is important for managing clinical pharmacy services. 
Managing clinical pharmacy services will remain a challenge. Planning appropriate 
services, matching resources to workload and needs, and meeting the rapid changes in 
hospital diversification requires substantial pharmacy management knowledge and 
expertise (Dzierba, 1990).  Clinical pharmacy leaders and mangers  should enjoy 
excellence in clinical pharmacy management. Attributes of excellence in  clinical 
pharmacy management are: big- picture thinking, the ability to exploit change, and 
willingness to take risks.  Big picture thinking means understanding trends that are 
shaping health care in order to determine where pharmacy fits.  Pharmacists need 
flexibility to adopt and to change.  They need to learn about the clinical, behavioral, 
operational, and fiscal aspects of managing  the patient ( Shane, 1996). 
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key informants insisted that a  key step in meeting the  challenges of managing 
clinical pharmacy services,  is integrating the pharmacist's responsibilities for drug 
information and drug prescription.  This step ensures the provision of the highest 
quality clinical  pharmacy services.  If clinical pharmacy services  is managed 
appropriately, then it will affect positively the success of the implementation process 
and this is considered  driving force.  If it is, in the other hand not managed 
appropriately then this will impair the process,  and add more constrains to the 
implementation process.  
Pharmaceutical Quality Improvement Committee proposed a job description for 
clinical pharmacists. Presence of job description proven to be an effective instrument 
that states  work regulations , responsibilities and standards. The proposed Job 
Description , despite being only proposed ,  remains a good factor that enables clinical 
pharmacists to understand many roles regarding their profession, this is according to 
key informants point of view. 
 
5.15 Attribution of Pharmacy College in the Profession of Clinical 
 Pharmacy (Driving Force) 
 
All key informants considered development of pharmacy college curricula as driving 
force that will help in the future preparation of clinical pharmacists.  The increasing 
number of pharmacy graduates will provide more and more manpower that support 
the trend regarding implementing clinical pharmacy services.  They revealed that 
decision makers of pharmacy college, health policy planners in MOH and General 
administration of pharmacy must work closely with the profession, particularly in the 
areas of experimental education, and develop new patient-centered practice model.  
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Professionals must work together patiently, honestly, and meaningfully to revise 
pharmacy's practice systems to support a level of patient care that genuinely affects 
patient's drug therapy outcomes (ACCP, 2000). 
Key informants revealed that the residency program that can be attended by each 
pharmacy student in governmental hospitals and primary care centers, is considered 
another factor that the pharmacy college represents to support clinical pharmacy 
profession.  Residency program provides an empowering practice environment, that 
makes new graduates feel not disenchanted from what they have learned. 
In the absence of an empowering environment, new graduates become disenchanted 
by the mismatch between what they are taught and what they actually do and more 
mature members of the profession grow increasingly convinced that the academy has 
lost touch with the real world (ACCP, 2000).  
 
5.16  Well and desire to work as clinical pharmacist (Driving  Force) 
 
20  key informants considered the well and desire of the selected hospital pharmacists 
to work as clinical pharmacists, as driving force that help in the effective 
implementation of clinical pharmacy services. 
Pharmacists' success will depend on their willingness to experiment with new 
services and discard services that do not substantially advance patient care. 
Pharmacists must monitor changes in the provision of health care, determine 
the    implications for their practice and seek opportunities for participation 
outside the 
walls within which they have traditionally practiced (Shane, 1996).  Selection of the 
pharmacist to act as clinical pharmacist was based on their well and desire to act as 
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clinical pharmacist, according to the key informants this way of selection was 
convenient because there is no differences between pharmacists.  All of them are a 
bachelor degree holder, so no specific exams was made to test  their knowledge 
regarding  clinical pharmacy science and practice. Lack of any special credits for any 
pharmacist who wants to work as clinical pharmacist, despite the fact that he/she will 
suffer from  time constrain and work load, makes this way of selection convenient at 
this stage.  
The 20 key informants believed that welling to act as clinical pharmacist is considered 
as driving force that support the implementation process, in the same time if such well 
is going to fade away because of lack of support, then it will be a major holding back 
force, because the pharmacist will simply turn his back and return to act as drug 
dispenser in the ward pharmacy.  It is important to protect this well and make it grow 
more urgently by time, good pharmacy management will keep it running. 
 
5.17   lack of mentality regarding the profession (Holding Back 
Force) 
 
25 key informants revealed that absence of mentality regarding the nature of the 
profession of clinical pharmacy is one of the main holding back force that my 
negatively affect the implementation process.  All key informants revealed that this 
lack of mentality is due to two main factors, first No information culture regarding the 
profession of clinical pharmacy and second Lack of philosophy that regulates the 
whole clinical pharmacy discipline. 
Administrators of most health-care plans do not believe that pharmacists can make 
contributions well beyond their traditional distributive duties.  They do not hold 
 134 
pharmacy managers accountable for ensuring appropriate drug therapy outcome 
(Scroccaro, et al. 2000).  Key informants revealed that clinical pharmacy terminology 
is totally new for most health care providers and administrators.  To most of them it is 
a vague terminology as they related to pharmacists, ironically this term is used 
worldwide by different health care systems. Illiteracy about clinical pharmacy 
benefits and services would impose more constrains that will resist the effectiveness 
of the implementation process. 
 
5.18  A administrational Changes and Instability (Holding Back 
Force) 
 
24 key informants considered administrational changes and instability as a mjor 
holding back force. By reviewing  all the decisions regarding  the implementation of 
clinical pharmacy in MOH hospitals and , by visiting the hospitals  which is selected 
to implement the services in, a number of factors seemed to affect the effectiveness of 
the implementation process in both directions, this was revealed also by key 
informants who had a consensus regarding the a administrational changes and 
instability. 
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5.18.1  MOH Administrational Decisions  and Health  System 
Policies: 
 
Holding back forces that is related to the system is called system related barriers 
which is a result of fragmentation of health care system (Al-Shagha, and Zairi, 2001). 
By reviewing the decisions taken by MOH regarding clinical pharmacy 
implementation, it was found that some decisions were for the sake of the 
implementation process and acted as driving force that supported  the issue, and some 
were one of the basic holding back force that hindered the continuity of the  
implementation process. 
Ministry of health in April 2004  gave an approval for the implementation of clinical 
pharmacy in the MOH hospitals, this made pharmacy leaders within the General 
Administration of Pharmacy  start acting effectively to update the approach and 
implement the services.  Pharmaceutical Quality Improvement Committee was in 
charged by the General Director of pharmacy to start selecting pharmacy staff 
members and to try to implement some sort of clinical pharmacy services in selected 
governmental hospitals.  In Aug 2005, there was another Ministry decision which  
limit the authority of the General Administration of Pharmacy, and restrict its role  
towards hospital pharmacists and primary 
 
 health care centers pharmacists and referring them to their administration  directors 
of hospitals and primary care centers where they  work (Annex 8). 
This decision was described by one of the key informants as the gun shot directed 
towards the head of the  clinical pharmacy implementation process. 
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For three consecutive months (8/2005-11/2005), there was disconnection and lack of 
communication  between pharmaceutical quality improvement committee and hospital 
pharmacists, this is a major factor that influenced the implementation process in a 
negative way.  
  In practice clinical pharmacists were completely disconnected, and detached away 
from the committee which is supposed to provide training courses , support, follow up 
and evaluation.  One of the pharmacists who was selected to act as a clinical 
pharmacist in Abu Yusif Al Najar  hospital in Rafah city was transferred to work in 
Tal El -Sultan  hospital in the same city.  None of the Pharmaceutical Quality 
Improvement Committee knew about the decision, the General Director of Pharmacy 
revealed that the decision was taken without his knowledge or his consultation. 
In order for the change to be successful and effective there must be law empowerment 
that support that change.  If decisions are taken individually and without taking the 
new profession value into consideration,  then it will fail, and no much outcome will 
be gained (Mullins, 1996). 
 
5.18.2 Hospital Administration and Hospital Pharmacy Settings: 
 
According to what is revealed by key informants, some types of hospitals in Gaza 
Strip will have higher level of clinical pharmacy services, and some will have lower. 
This is because each hospital differ from the other in a mostly every thing.  For 
example Gaza European hospital  pharmacy adopt unit dose system, full computerized 
system is available and accessible to every pharmacists, and references are available 
and attainable.  While the other hospitals have ward pharmacies  and even if they have 
computers in the hospital setting then it is not accessible to every pharmacist. 
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Managers and directors of hospitals are usually physicians who have different 
perception regarding the role of the clinical pharmacist and the importance of clinical 
pharmacy services. Some of the hospital managers were cooperative and were welling 
to provide support, others were not impressed by the idea and even prevented ( 
indirectly) the pharmacists from acting as clinical pharmacists.  This could be solved 
by special orientation courses to be given to directors of hospitals regarding the 
importance of clinical pharmacy profession to the health system and by MOH logistic 
support. 
 
5.19    Intra  professional barriers (Holding Back Force) 
 
According to 23 key informants, intra professional barriers is considered a holding 
back force that should be overcame to get the maximum benefit of implementing 
clinical pharmacy services. They expressed that these barriers exist not only between 
clinical pharmacists and other health team members, but also between the clinical 
pharmacists and ward pharmacists.  
One of the most important duties of the clinical pharmacists is to monitor drug related 
problems and medication errors that affect the patient's quality of life.  This require 
revising drug prescribed for possible drug interaction, food drug interactions, 
hypersensitivity reactions, the way by which the drug is prepared and administrated, 
and  appropriate drug dose regimen.  This may be considered as interruption in the 
work of both the physicians and the nurses if  nature of clinical pharmacy services is 
not fully understood (Lopez, et al. 2002).  
 The nature of clinical services to be provided may be misconceived and 
misunderstood by both the physicians  and the nurses, this may affect negatively the 
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team work interaction leading to many work problems, health team members  should 
know and understand that the role of the clinical pharmacist is complementary and not 
compensatory.  No one is going to replace another , it is just a cooperation process 
between different team members to optimize health care delivered for patient for the 
sake of improving his quality of life (Watanabe, et al. 2005). 
 
5.20 Clinical Pharmacy Staff Related Factors (Staffing Factors) 
 
The twenty pharmacists whom  were selected by the General Administration of 
pharmacy to become in practice clinical pharmacists were a Bachelor degree holders, 
non of them had special training courses.  Prior to the selection  process there was an 
announcement  that is distributed to all hospitals in Gaza Strip, the announcement was 
about pharmacists who are welling to work as clinical pharmacists.  The pharmacists 
who liked and desired to work as clinical pharmacists were interviewed, then 20 
candidate were selected according to their well and desire to act as clinical 
pharmacist.  These twenty pharmacists were hospital pharmacists who were 
distributed among nine MOH hospitals, where they originally worked before 
conducting the interview, that means that no pharmacist had to change the hospital in 
which he/she is originally used to work.  A detailed job and duties guideline was 
given and distributed among the 20 pharmacists, these guidelines regulate the 
relationship between the pharmacists and other health team providers, and describes 
the duties of the clinical pharmacist. Special orientation course about the concept of 
clinical pharmacy was given to the 20 pharmacist.  The Pharmaceutical Quality 
Improvement Committee named theses 20 pharmacists "in practice clinical 
pharmacist" in order to differentiate them from professional clinical pharmacist due to 
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their lack of knowledge and expertise regarding clinical pharmacy practice and 
science.      
On 5/7/2005 the pharmacists were asked to start practicing clinical pharmacy 
activities in selected departments of the hospitals they are chosen to work in, the 
selection of the specific department was based on the well and knowledge of the 
pharmacist and on the relationships they had with the department's health team 
members. Most of the  pharmacists started attending the morning round and meeting, 
reviewing patients profile, observing drug prescribed and make special notes about it.  
 
5.20.1   Lack of Specialized  Knowledge and Expertise  
              (Holding Back Force): 
 
24 key informant revealed that lack of specialized scientific and communication 
training courses is considered a holding back force.  Key informants believed that lack 
of specialized knowledge and expertise negatively affect in practice clinical 
pharmacist's performance, lower confidence level and self image and lead to creation 
of different goals and attitudes of individual pharmacists. 
Different attitudes and goals of individual pharmacists often contribute to lack of 
cohesiveness. Pharmacists' perceptions of goals for clinical pharmacy services, as 
well as the proportion of time devoted to clinical services, are very important in the 
clinical pharmacists achievements in the working field ( Guerrero, et al. 1990). 
Many pharmacists choose not to intervene in a patients drug therapy because they do 
not believe that they have a role in disease prevention.  They posses unfounded fear 
that there is increased risk of professional liability associated with prescription 
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interventions or they believe their duty to counsel is completed after asking the 
patient, `` Did your physician tell you how to take this medicine?`` (ACCP, 2000) 
Confidence and self image are important prerequisites  for pharmacists who seek to 
perform health care functions that traditionally have been carried by other health 
professionals.  Good perception and positive  self concept will greatly support the 
services to be delivered by the pharmacist, lack of such perception will impair the 
ability of the pharmacist to perform the services he  is supposed to deliver.  The only 
solution in this case is to give special training courses regarding that issue and to 
increase pharmacist competence and level of knowledge and expertise (Phillips, et al. 
1987). 
All the  pharmacists that were  selected to act as clinical pharmacist are a Bachelor 
degree holders, they have studied basic pharmaceutical science without any 
specialized courses or training courses regarding clinical pharmacy. According to key 
informants theses pharmacists are not well  trained to deal with the information 
gained, they are not trained to seek  the appropriate information that has credibility in 
the pharmaceutical world, and even if they find such information they are not trained  
to use it in the appropriate way, or to communicate it to its target health providers, 
community, or patients. No specialized courses are given to these pharmacists to 
increase and enhance their knowledge and expertise, the Pharmaceutical Quality 
Improvement Committee prepared a set of lectures to be given, but unfortunately till 
the moment the researcher is doing his assessment no training courses were  given to 
them.  According to the 24 key informants a new assessment of the pharmacy college 
curriculum should be made and the selection of clinical pharmacist should be based 
on the knowledge and expertise.  This will put much more value on the quality of 
services to be delivered by them and the validity of outcome gained.  They also 
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revealed that professionalized clinical pharmacists will be the main driving force in 
the implementation process.   It is not difficult to give the pharmacists the courses 
required to make them professional clinical pharmacists. What pharmacy leaders 
should do is simply putting the pharmacists on the track and provide them adequate 
support, educational materials, training courses and motivate them by inspiring them 
day by day to act as clinical pharmacy professionals.  
 
5.20.2  Lack of communication skills training  programs 
           (Holding Back Force): 
 
According to 24 key informants, lack of communication skills training courses is 
considered one of the holding back forces that may impair the effectiveness of clinical 
pharmacy services provided.  
The interpersonal skills of pharmacists are underdeveloped and undervalued, these 
skills are crucial to success in many interactions with patients, and other health care 
professionals. Pharmacy education may have neglected the link between 
communication ability, human relations skills, and effective professional practice 
(ACCP, 2000). 
Key informants revealed that selected pharmacists did not receive any communication 
skills training courses that enable them to communicate effectively with health team 
members and with patients. This  requires specific training courses that  are effective 
in enabling pharmacists  to communicate in a proper way, and to deliver the medical 
information in a way that minimize the intra professional barriers that coexist 
normally between health care providers. 
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5.20.3  Insufficient work force and manpower (Holding Back force): 
  
24 key informants revealed that the selected number of pharmacists to act as clinical 
pharmacists is inconvenient and insufficient and may considered as holding back 
force that affect the effectiveness of the implementation process. 
…We must work to solve the challenges of attaining adequate numbers of 
pharmacists to manage the increasing prescription volume, and adequate support help 
for dispensing functions, so pharmacists may devote an appropriate amount of time to 
direct patient care (ACCP, 1999). 
According to key informants there is currently an inadequate supply of clinically 
trained pharmacists to deliver widespread patient care.  Despite the fact that the 
selected number of pharmacists  is not sufficient but it is enough to start with, because 
by reviewing how clinical pharmacy was implemented in different worldwide 
hospitals , it was found that in the first stage of implementation one department of one 
specific hospital could be started with, then different departments would follow 
(Lopez, et al. 2002). 
Reconsidering number of pharmacists provided for different departments on basis of 
bed occupation rate, continuity of provision of clinical observation and follow up will 
promote better understanding of the effect of manpower availability for the sake of 
both, clinical pharmacy profession and  patients quality of life (ACCP, 2000).  
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5.21   Lack of Motivation and Rewards (Holding Back Force) 
 
20 key informants revealed that lack of rewards and motivation is considered one of 
holding back forces that will affect badly the performance of in practice clinical 
pharmacists. 
Motivation is proven to be the key element in maximizing quality of work obtained by 
any worker in any field, regarding clinical pharmacy which a new specialty to be 
introduced and implemented provision of motivation incentives will be crucial for 
pharmacists who are selected to act as clinical pharmacists. Lack of motivation will 
lead to frustration, job burnout and finally job turn over (Mullins, 1996). 
According to key informants, monetary motivation is not the sole motivating factor 
that may innovate health workers, despite it's critical importance in managing the 
daily requirements. Pharmacy leaders should find innovative way to motivate clinical 
pharmacy staff members since they are the nucleus of the beginning of the 
implementation process. Self celebration is one of the key factors that is effective and 
cost nothing in monetary aspect.  Allow the pharmacist to express new things he/she 
learned , good and scientific based interventions he/she made, credible medical 
information he/she provided, no suppression of innovative ideas.  Conducting  
workshops to exchange information and expertise among clinical pharmacy staff 
members will be brain storming to them and challenging to update their knowledge 
and present it in a credible way.  This will keep them warmed up.  Key informants 
believed that creation of incentives and motivating factors still very challenging and 
brain storming to pharmacy leaders and managers to protect pharmacy members from 
frustration related work problems. 
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5.22  Lack of  References and Resources (Holding Back Force) 
 
24 key informants revealed that lack of references and resources is considered of the 
holding back forces. Provision of credible updated references is very important for 
improving clinical pharmacy information and knowledge.  Key informants believed 
that references and resources of credible medical information  are very important for 
attaining credible updated medical information.  Lack of such resources will serve as 
draw back force that negatively impact pharmacist`  knowledge and performance.  
Most of the clinical pharmacy staff team  members lack credible reference, and online 
information database, only pharmacists who work in Gaza European hospital 
pharmacy and Al Nasser pediatric pharmacy  have good credible references and  
accessibility to on line information. 
Sufficient credible references should be provided in order to allow clinical 
pharmacists to perform their clinical pharmacy services in a credible professional 
manner. 
 
5.23   Lack of  Follow up and evaluation (Holding Back Force) 
 
According to 25 key informants lack of follow up and evaluation is considered one of 
the obstacles that face the implementation process. 
Follow up and evaluation  are very important in monitoring performance and clinical 
pharmacy services outcome.  Pharmaceutical Quality Improvement Committee is 
responsible for follow up and evaluation of clinical pharmacy services.  Till now there 
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is no written guideline that regulate and guide the evaluation process, this is a 
drawback point in the management of good clinical pharmacy practice.  
 Clinical pharmacist is in need of knowing on what basis, he/she is going to be 
evaluated in order to organize and monitor his performance in a successful manner 
(Boardman and Fitzpatrick, 2001). 
Key informants revealed that no formal evaluation was made in order to know the 
factors that may support, hinder, threat or enhance the implementation process.  Till 
now, there is no process evaluation to know how clinical pharmacists are performing  
their duties within the hospital setting.  For example are they all doing clinical 
pharmacist job assignment or do they work as drug dispensers?  
Since Aug 1, 2005, the date on which the Ministry decision No. 34 was issued, and till 
Nov 11, 2005 there still  no communication between any member of the committee 
and the selected pharmacists.  Now  some  in Practice clinical pharmacists are acting 
as drug dispensers, and are not attending the morning meeting, or physicians rounds 
for many reasons, one of them is lack of follow up and evaluation.   
 
5.24    Time Constrains and work load  (Holding Back Force) 
 
15 pharmacists believed that in practice clinical pharmacists will suffer from time 
constrains and heavy workload, this is because in practice clinical pharmacists is 
asked to do two jobs, one of them to work as clinical pharmacist and the other is to 
participate in dispensing and distributing medicine in the ward pharmacy. 
Pharmacists complain that the volume and time demands of dispensing prescriptions 
preclude using drug therapy knowledge to help patients, thus enough time should be 
provided to deliver patient oriented services ( ACCP,2000). 
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Pharmacists who are selected to work as clinical pharmacists have to do about 11 
duties  every day according to the Job description, in the same time most of these 
pharmacists should participate in the dispensing process in the ward pharmacy and 
make sure that  quantity of drug is maintained  in its legal level.  According to the 15 
key informants this present  a very heavy work load and time constrain which will 
affect so badly the quality of clinical services provided.  Freeing in practice 
pharmacist time, and in charge him/her with clinical pharmacy duties will optimize 
clinical pharmacists performance, and  improve quality of outcome gained. 
The manager of a clinical pharmacy program must define a comprehensive list of 
clinical activities for pharmacists. the expected benefits of each activity for the 
patient, physician, and nurse must be descried in the same time, close attention should 
be paid to the pharmacist's time for clinical practice (Denisco, 1986). 
5.25  Inappropriate workplace and working environment 
           (Holding Back Force) 
15 key informants revealed that there is no appropriate work place and working 
environment that support clinical pharmacy services.   
There should be physical facilities to help the pharmacist in providing  clinical 
pharmacy services.  Lack of physical facilities limit the ability of pharmacists to 
provide clinical pharmacy services.  Dedicated areas, in which the pharmacist can 
provide patient consultation or drug therapy information are often lacking (Al- 
Shaqha, and Zairi, 2001).  
In reviewing the activities of hospital pharmacy,  one must conclude that no two 
hospitals practice are a like.  With the exception of Gaza European hospital, all 
hospital pharmacies are alike regarding the narrow place available for both 
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pharmacists and drugs, ward system pharmacists and lack of computerized system 
that is connected to internet  that is accessible to all  pharmacists. 
Key informants revealed that most of the pharmacists who is supposed to practice 
clinical pharmacy have no place to put their books and reports, no environment that 
support reading and filling reports of patients, no time to read and do researches, and 
finally no logistic support to practice clinical pharmacy activities.  
Key informants revealed that till now,  the in practice pharmacist who is  supposed to 
work as a clinical pharmacist is  considered as one of the hospital pharmacy members, 
whose duty is to dispense drugs to different pharmacy departments and watch for the 
drug quantity. Till now there is no consensus regarding the place of the clinical 
pharmacist, 10 key informants revealed that the appropriate place for the clinical 
pharmacist is in the hospital pharmacy to which he/she belongs because he/she still a 
member of the pharmacy. 4 key informants  said that the place of the pharmacist is in 
the physicians room because he/she is a member of the medical team and his presence 
will allow maximum exchange of medical information with the physicians, 11 key 
informant said that there must a separate workplace for the clinical pharmacist to act 
on the patient files and reports and to do the researches that is required to be done. It 
is important to provide  a place at which the pharmacist could perform the activities 
he is required to do, that place should be provided with physical facilities that support 
the work. The future health care environment will hold many opportunities for 
pharmacists,  if the leadership and management of the profession can respond quickly 
to focus the profession's efforts on improving patients` drug therapy outcome.  The 
role of future pharmacy leaders will be to establish innovative working environments 
by projecting a unifying vision for the profession and providing monitoring to 
pharmacy managers and staff  (ACCP, 2000). 
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Chapter 6 
 
Conclusion and recommendations 
 
6.1  Conclusion 
 
The pharmacy profession in Gaza Strip MOH hospitals has many challenges ahead, 
and it is hoped that every practicing pharmacist will be highly committed to future 
professional needs so that clinical pharmacy practice becomes a reality. 
MOH  is capable of implementing clinical pharmacy services in its  hospitals and 
perhaps also in the community setting. The important factors in clinically oriented 
pharmacy practice include improvement of the drug-control process, development of 
physical and human resources, clinical pharmacy skills, and the training of practicing 
pharmacists. A number of Palestinian  pharmacists have already developed a unit-
dose drug distribution system especially in Gaza European hospital pharmacy. 
Many factors may promote the implementation process like the need for economic 
efficient approach that decrease the MOH medicines expenditure, improving patient 
quality of life, provision of an ideal teamwork and a new step towards the profession 
of pharmacy. 
Nevertheless implementing clinical pharmacy services in MOH hospitals still in its 
primary phase, and the implementation process faces many holding back forces which 
are able of hindering the effectiveness of the implementation process.  
Administrational changes and instability are considered the main holding back force 
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that may stop the implementation process once and for all, lack of mentality regarding 
the profession of clinical pharmacy, lack of specialized scientific and communication 
skills training courses, intra professional barriers, scarce resources and references and 
inappropriate work place and working environment are considered of the main 
holding back forces. 
Also lack of rewards and motivation and time constrains and heavy workload are 
considered of the factors that may affect the implementation process negatively. 
The time has come to unify the profession of pharmacy in pursuit of its patient care 
mission, pharmacy is maturing as clinical profession and it will be well positioned to 
transfer itself from a product oriented to a patient oriented profession. 
Hospital pharmacies are alike regarding the narrow place available for both 
pharmacists and drugs.  Key informants revealed that most of the pharmacists who is 
supposed to practice clinical pharmacy have no place to put their books and reports, 
no environment that support reading and filling reports of patients, no time to read 
and do researches and finally no logistic support to practice clinical pharmacy 
activities. 
The future health care environment will hold many opportunities for pharmacists, if 
the leadership and management of the profession can respond quickly to focus the 
profession's effort on improving patient's drug therapy outcome.  The role of future 
pharmacy leaders will be to establish innovative working environments by projecting 
a unifying vision for the profession and providing monitoring to pharmacy managers 
and staff (ACCP, 2000).    
The clinical pharmacy profession  as a whole must dedicate itself to a philosophy of 
practice that clearly identifies the patient as its primary beneficiary.  Several factors 
may serve to impair the adoption of new roles, including lack of consensus  regarding 
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the profession goals, resistance to broad the pharmacists` responsibilities beyond 
dispensing functions, lack of professional competence and/or self-confidence, work 
environments that provide little or no opportunity for patient-centered practice, lack of 
practitioners communication skills.  Factors that appear likely to promote changing 
professional roles include opportunity to positively impact patients drug therapy 
outcome through disease state management and , increased demand for drug 
information among health professionals and consumers.  For the success of the 
effectiveness of  implementation process , first of all there, a law empowerment will  
support the implementation process.  If additional decisions to be taken and without 
considering the value of the new profession the implementation process will fail to 
approach the concept, and poor outcome will be gained. 
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6.2  Recommendations 
 
A number of  steps should be considered as pharmacy prepares to shift toward a 
profession-wide, patient- centered practice model. 
1-  MOH should adopt a unifying philosophy of practice that establishes the patient as 
the primary beneficiary of the profession, with the pharmacist accepting share 
responsibility with other health care professionals  for patient care. 
2-- Workshops should be conducted to health care providers to introduce the term 
``clinical pharmacy`` to them. 
3- Establishment of  Clinical Pharmacy department and give it the freedom , power of 
law and authority to organize the clinical pharmacy services and direct it's activities.  
 4- Revise  Pharmacy practice system to support a level of patient  care that genuinely 
impacts health outcome 
5- Continuous education program regarding both clinical pharmacy science and 
communication skills should be given to clinical pharmacists.  
6- Pharmacy faculty and pharmacy administration leaders need to provide the 
experience and cooperation necessary to develop efficacious education and training 
programs that can enhance the clinical practice abilities of clinical pharmacists. 
 7- Provide clinical pharmacists with enough credible references of scientific journals 
and books in addition to internet access. 
8- Logistic support needs to be provided by MOH to ensure the effectiveness of the 
implementation process.  
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6.2.1 Future research recommendations: 
 
1. Study challenges of implementing clinical pharmacy services in West Bank. 
2. Evaluate the effects of implementing clinical pharmacy services on the quality 
of health services provided. 
3. Evaluate compliance of in practice clinical pharmacists to the international 
standards of clinical pharmacy practice. 
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Annex 1: Data Collection instrument 
Focus interview of loosely structured questions 
 
1- What is your expectation of clinical pharmacy impact on patient life, health, 
economy, medical team work and profession of pharmacy? 
2- What is the staffing level needed, career development, and structure and 
service development? 
3- How are clinical pharmacy services organized in terms of personnel, 
management and constrains? 
4- What are the expected role of a clinical pharmacist to play in the hospital, 
what are the resources and references that are available? 
5- What are the staffing problems that may hinder the implementation of clinical 
pharmacy? 
6- What are the factors that may support, encourage and motivate implementing 
clinical pharmacy services in the MOH hospitals? 
7- What are the factors that may hinder , slow or block the effectiveness of the 
implementation process? 
8- Was there any special training courses for preparing clinical pharmacists? 
How they were selected? 
9- Will there be any clinical pharmacy support services like medicines 
information service, medication error reporting schemes, drug utilization 
reviews…etc? 
10- Will there be any rewards or advance cements for clinical pharmacy 
practitioners? 
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نموذج موافقة لاجراء بحث 
فلسطين - كلية الصحة العامة
 htlaeH cilbuP fo loohcS
القدس - فلسطين
 
اٌّذزشِخ /اٌّشبسوخ                                                  اٌّذزشَ/دضشح اٌّشبسن
ػٍّب ثأْ ٘زٖ اٌذساعخ ً٘ , ألَٛ ثذساعخ دٛي رذذٌبد رطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد فٍغطٍٓ اٌذىٍِٛخ
. فٍغطٍٓ-ِزطٍت ٌٍذظٛي ػٍى دسجخ اٌّبجغزٍش فً اٌظذخ اٌؼبِخ ِٓ جبِؼخ اٌمذط
اٌٙذف ِٓ ٘زٖ اٌذساعخ ٘ٛ ٚطف اٌؼٛاًِ اٌزً لذ رشجغ رطجٍك اٌظٍذٌخ اٌغشٌشٌخ فً ِغزشفٍبد فٍغطٍٓ 
. اٌذىٍِٛخ ٚوزٌه اٌؼٛاًِ اٌّضجطخ اٌزً رؼٍك ِضً ٘زا اٌزطجٍك
أرطٍغ ٌّشبسوزىُ فً إرّبَ ٘زٖ اٌذساعخ اٌزً ٌٍغذ ٌِّٛخ ِٓ أي جٙخ وبٔذ ٚ ٌٓ ٌزشرت ػٍى ِشبسوزىُ فٍٙب 
. أوضش ِٓ اٌٛلذ اٌلاصَ لإرّبَ اٌّمبثٍخ
 دلٍمخ ٚعٍىْٛ 06-53عٍزُ جّغ اٌجٍبٔبد ِٓ خلاي اٌّمبثٍخ اٌشخظٍخ ٌّشح ٚادذح فمظ ٌٚغزغشق رٌه رمشٌجب ِذح 
ٌذك ٌىُ الإجبثخ أٚ الاِزٕبع ػٓ اجبثخ أي ِٓ الأعئٍخ اٌزً عزٛجٗ , رٌه طجبدب خلاي عبػبد اٌؼًّ اٌشعًّ
. ٚفً دبي اٌّٛافمخ عٍزُ ادزشاَ عشٌخ اٌّؼٍِٛبد اٌزً عزذٌْٛ ثٙب, إٌٍىُ
. ٚشىشا ٌذغٓ رؼبٚٔىُ
                                                                                                 اٌجبدضخ                                                  5002/   / اٌزبسٌخ   
أٍِشح طذلً شؼذ 
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Annex 15: Informed Consent (English Copy)  
Informed Consent 
Dear participant: 
You are chosen to be a participant for this research, challenges of implementing 
clinical pharmacy services at Palestinian governmental hospitals. 
You are selected for your knowledge and expertise and because you have met the 
selection criteria for participation. 
This study is being carried out as a part of the requirements for the master degree of 
public health at Al_Quads University, school of public health Palestine. 
The study is self funded and there is no commitment if you participate except the time 
needed to complete the interview which is 35-60 minutes during the working hours in 
the morning.  You have the right to answer or refuse to answer any questions of the 
interview. 
The aim of this study is to identify the driving forces and holding back forces that 
may influence the implementation process of clinical pharmacy services in the 
governmental hospitals. 
I appreciate your participation in this research. 
Best wishes 
Date:  /   /2005                                                               Researcher 
                                                                           Amera Sedkey Shaat  
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